BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, Zhang D, Su Z, Fang Z, Lan Z, Li J, Xiao L, Li J, Li R, Li X, Li F, Ren H, Huang Y, Peng Y, Li G, Wen B, Dong B, Chen JY, Geng QS, Zhang ZW, Yang H, Wang J, Wang J, Zhang X, Madsen L, Brix S, Ning G, Xu X, Liu X, Hou Y, Jia H, He K, Kristiansen K. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8:845. [PMID: 29018189 DOI: 10.1038/s41467-017-00900-1] [Cited by in Crossref: 424] [Cited by in F6Publishing: 400] [Article Influence: 84.8] [Reference Citation Analysis]
Number Citing Articles
1 Dovrolis N, Filidou E, Kolios G. Systems biology in inflammatory bowel diseases: on the way to precision medicine. Ann Gastroenterol 2019;32:233-46. [PMID: 31040620 DOI: 10.20524/aog.2019.0373] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol 2020;17:327-40. [PMID: 31996800 DOI: 10.1038/s41569-019-0326-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 25.5] [Reference Citation Analysis]
3 Zhou W, Cheng Y, Zhu P, Nasser MI, Zhang X, Zhao M. Implication of Gut Microbiota in Cardiovascular Diseases. Oxid Med Cell Longev 2020;2020:5394096. [PMID: 33062141 DOI: 10.1155/2020/5394096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Roth WH, Cai A, Zhang C, Chen ML, Merkler AE, Kamel H. Gastrointestinal Disorders and Risk of First-Ever Ischemic Stroke. Stroke 2020;51:3577-83. [PMID: 33040706 DOI: 10.1161/STROKEAHA.120.030643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Rajendiran E, Ramadass B, Ramprasath V. Understanding connections and roles of gut microbiome in cardiovascular diseases. Can J Microbiol 2021;67:101-11. [PMID: 33079568 DOI: 10.1139/cjm-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bavineni M, Wassenaar TM, Agnihotri K, Ussery DW, Lüscher TF, Mehta JL. Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood. Eur Heart J 2019;40:1107-12. [PMID: 30753448 DOI: 10.1093/eurheartj/ehz025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
7 Zhang L, Shi Y, Jenq RR, Do KA, Peterson CB. Bayesian compositional regression with structured priors for microbiome feature selection. Biometrics 2021;77:824-38. [PMID: 32686846 DOI: 10.1111/biom.13335] [Reference Citation Analysis]
8 Daisley BA, Koenig D, Engelbrecht K, Doney L, Hards K, Al KF, Reid G, Burton JP. Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases. Cell Rep 2021;37:110087. [PMID: 34879270 DOI: 10.1016/j.celrep.2021.110087] [Reference Citation Analysis]
9 Proffitt C, Bidkhori G, Moyes D, Shoaie S. Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions. Microorganisms 2020;8:E1381. [PMID: 32916966 DOI: 10.3390/microorganisms8091381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li XL, Cui JJ, Zheng WS, Zhang JL, Li R, Ma XL, Lin M, Guo HH, Li C, Yu XY, Du P, Zhao LM, He S, Lan P, Jiang JD, Che Y, Wang LL. Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota. Small 2022;:e2105021. [PMID: 35088527 DOI: 10.1002/smll.202105021] [Reference Citation Analysis]
11 Honda Y, Itano S, Kugimiya A, Kubo E, Yamada Y, Kimachi M, Shibagaki Y, Ikenoue T. Laxative use and mortality in patients on haemodialysis: a prospective cohort study. BMC Nephrol 2021;22:363. [PMID: 34732171 DOI: 10.1186/s12882-021-02572-y] [Reference Citation Analysis]
12 Talmor-Barkan Y, Bar N, Shaul AA, Shahaf N, Godneva A, Bussi Y, Lotan-Pompan M, Weinberger A, Shechter A, Chezar-Azerrad C, Arow Z, Hammer Y, Chechi K, Forslund SK, Fromentin S, Dumas ME, Ehrlich SD, Pedersen O, Kornowski R, Segal E. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat Med 2022. [PMID: 35177859 DOI: 10.1038/s41591-022-01686-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Dubinski P, Czarzasta K, Cudnoch-Jedrzejewska A. The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress. Curr Hypertens Rep 2021;23:31. [PMID: 34014393 DOI: 10.1007/s11906-021-01144-7] [Reference Citation Analysis]
14 Sudun S, Liu S, Xiao C, Peng C, Liang L, He X, Zhao S, Zhang G. Probiotic strains improve high-fat diet-induced hypercholesterolemia through modulating gut microbiota in ways different from atorvastatin. Food Funct 2019;10:6098-109. [DOI: 10.1039/c9fo00444k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chen J, Qin Q, Yan S, Yang Y, Yan H, Li T, Wang L, Gao X, Li A, Ding S. Gut Microbiome Alterations in Patients With Carotid Atherosclerosis. Front Cardiovasc Med 2021;8:739093. [PMID: 34869642 DOI: 10.3389/fcvm.2021.739093] [Reference Citation Analysis]
16 Yoshida N, Yamashita T, Hirata KI. Gut Microbiome and Cardiovascular Diseases. Diseases 2018;6:E56. [PMID: 29966270 DOI: 10.3390/diseases6030056] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
17 Cao Y, Liu H, Qin N, Ren X, Zhu B, Xia X. Impact of food additives on the composition and function of gut microbiota: A review. Trends in Food Science & Technology 2020;99:295-310. [DOI: 10.1016/j.tifs.2020.03.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 14.5] [Reference Citation Analysis]
18 Wu C, Daugherty A, Lu HS. Updates on Approaches for Studying Atherosclerosis. Arterioscler Thromb Vasc Biol 2019;39:e108-17. [PMID: 30917052 DOI: 10.1161/ATVBAHA.119.312001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 2019;7:e7502. [PMID: 31440436 DOI: 10.7717/peerj.7502] [Cited by in Crossref: 95] [Cited by in F6Publishing: 77] [Article Influence: 31.7] [Reference Citation Analysis]
20 Zhong H, Ren H, Lu Y, Fang C, Hou G, Yang Z, Chen B, Yang F, Zhao Y, Shi Z, Zhou B, Wu J, Zou H, Zi J, Chen J, Bao X, Hu Y, Gao Y, Zhang J, Xu X, Hou Y, Yang H, Wang J, Liu S, Jia H, Madsen L, Brix S, Kristiansen K, Liu F, Li J. Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. EBioMedicine 2019;47:373-83. [PMID: 31492563 DOI: 10.1016/j.ebiom.2019.08.048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
21 Huang TT, Lai JB, Du YL, Xu Y, Ruan LM, Hu SH. Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies. Front Genet. 2019;10:98. [PMID: 30838027 DOI: 10.3389/fgene.2019.00098] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 20.0] [Reference Citation Analysis]
22 Shieh A, Lee SM, Lagishetty V, Gottleib C, Jacobs JP, Adams JS. Pilot trial of vitamin D3 and calcifediol in healthy vitamin D deficient adults: does it change the fecal microbiome? J Clin Endocrinol Metab 2021:dgab573. [PMID: 34343292 DOI: 10.1210/clinem/dgab573] [Reference Citation Analysis]
23 Nie J, Xie L, Zhao BX, Li Y, Qiu B, Zhu F, Li GF, He M, Wang Y, Wang B, Liu S, Zhang H, Guo H, Cai Y, Huo Y, Hou FF, Xu X, Qin X. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients. Stroke 2018;49:2021-8. [PMID: 30354996 DOI: 10.1161/STROKEAHA.118.021997] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 15.7] [Reference Citation Analysis]
24 Jin L, Shi X, Yang J, Zhao Y, Xue L, Xu L, Cai J. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell 2021;12:346-59. [PMID: 32989686 DOI: 10.1007/s13238-020-00785-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Danneskiold-samsøe NB, Dias de Freitas Queiroz Barros H, Santos R, Bicas JL, Cazarin CBB, Madsen L, Kristiansen K, Pastore GM, Brix S, Maróstica Júnior MR. Interplay between food and gut microbiota in health and disease. Food Research International 2019;115:23-31. [DOI: 10.1016/j.foodres.2018.07.043] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 23.3] [Reference Citation Analysis]
26 Huang Z, Zeng S, Xiong J, Hou D, Zhou R, Xing C, Wei D, Deng X, Yu L, Wang H, Deng Z, Weng S, Kriengkrai S, Ning D, Zhou J, He J. Microecological Koch's postulates reveal that intestinal microbiota dysbiosis contributes to shrimp white feces syndrome. Microbiome 2020;8:32. [PMID: 32156316 DOI: 10.1186/s40168-020-00802-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 16.0] [Reference Citation Analysis]
27 Lumelsky N, O'Hayre M, Chander P, Shum L, Somerman MJ. Autotherapies: Enhancing Endogenous Healing and Regeneration. Trends Mol Med 2018;24:919-30. [PMID: 30213702 DOI: 10.1016/j.molmed.2018.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
28 Stewart KL, Stewart AM, Bobik TA. Prokaryotic Organelles: Bacterial Microcompartments in E. coli and Salmonella. EcoSal Plus 2020;9. [PMID: 33030141 DOI: 10.1128/ecosalplus.ESP-0025-2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
29 Alhmoud T, Kumar A, Lo C, Al-sadi R, Clegg S, Alomari I, Zmeili T, Gleasne CD, Mcmurry K, Dichosa AEK, Vuyisich M, Chain PSG, Mishra S, Ma T. Investigating intestinal permeability and gut microbiota roles in acute coronary syndrome patients. Human Microbiome Journal 2019;13:100059. [DOI: 10.1016/j.humic.2019.100059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
30 Wang Z, Chen WH, Li SX, He ZM, Zhu WL, Ji YB, Wang Z, Zhu XM, Yuan K, Bao YP, Shi L, Meng SQ, Xue YX, Xie W, Shi J, Yan W, Wei H, Lu L, Han Y. Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation. Mol Psychiatry 2021. [PMID: 33963281 DOI: 10.1038/s41380-021-01113-1] [Reference Citation Analysis]
31 Katsimichas T, Antonopoulos AS, Katsimichas A, Ohtani T, Sakata Y, Tousoulis D. The intestinal microbiota and cardiovascular disease. Cardiovascular Research 2019;115:1471-86. [DOI: 10.1093/cvr/cvz135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
32 Jameson E, Quareshy M, Chen Y. Methodological considerations for the identification of choline and carnitine-degrading bacteria in the gut. Methods 2018;149:42-8. [PMID: 29684641 DOI: 10.1016/j.ymeth.2018.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
33 Huang K, Liu Y, Tang H, Qiu M, Li C, Duan C, Wang C, Yang J, Zhou X. Glabridin Prevents Doxorubicin-Induced Cardiotoxicity Through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice. Front Pharmacol 2019;10:107. [PMID: 30833897 DOI: 10.3389/fphar.2019.00107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
34 Guo Z, Chen Y, Chen S, Liu C, Li S, Chen P. Renal Denervation Mitigated Fecal Microbiota Aberrations in Rats with Chronic Heart Failure. Evid Based Complement Alternat Med 2021;2021:1697004. [PMID: 34691205 DOI: 10.1155/2021/1697004] [Reference Citation Analysis]
35 Xu DJ, Wang KC, Yuan LB, Li HF, Xu YY, Wei LY, Chen L, Jin KK, Lin QQ. Compositional and functional alterations of gut microbiota in patients with stroke. Nutr Metab Cardiovasc Dis 2021;31:3434-48. [PMID: 34666915 DOI: 10.1016/j.numecd.2021.08.045] [Reference Citation Analysis]
36 Rajakovich LJ, Fu B, Bollenbach M, Balskus EP. Elucidation of an anaerobic pathway for metabolism of l-carnitine-derived γ-butyrobetaine to trimethylamine in human gut bacteria. Proc Natl Acad Sci U S A 2021;118:e2101498118. [PMID: 34362844 DOI: 10.1073/pnas.2101498118] [Reference Citation Analysis]
37 van den Munckhof ICL, Kurilshikov A, ter Horst R, Riksen NP, Joosten LAB, Zhernakova A, Fu J, Keating ST, Netea MG, de Graaf J, Rutten JHW. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies: Impact of gut microbiota on low-grade inflammation. Obesity Reviews 2018;19:1719-34. [DOI: 10.1111/obr.12750] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 16.0] [Reference Citation Analysis]
38 Chen Y, Liu P, Liu R, Hu S, He Z, Dong G, Feng C, An S, Ying X. Comprehensive Strain-Level Analysis of the Gut Microbe Faecalibacterium prausnitzii in Patients with Liver Cirrhosis. mSystems 2021;6:e0077521. [PMID: 34342541 DOI: 10.1128/mSystems.00775-21] [Reference Citation Analysis]
39 Huang L, Guo H, Liu Z, Chen C, Wang K, Huang X, Chen W, Zhu Y, Yan M, Zhang D. Contrasting patterns of bacterial communities in the rearing water and gut of Penaeus vannamei in response to exogenous glucose addition. Mar Life Sci Technol. [DOI: 10.1007/s42995-021-00124-9] [Reference Citation Analysis]
40 Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 2020;113:2019-40. [PMID: 33136284 DOI: 10.1007/s10482-020-01474-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
41 Roth W, Mohamadzadeh M. Vitamin B12 and gut-brain homeostasis in the pathophysiology of ischemic stroke. EBioMedicine 2021;73:103676. [PMID: 34749301 DOI: 10.1016/j.ebiom.2021.103676] [Reference Citation Analysis]
42 Chiang MK, Hsiao PY, Liu YY, Tang HL, Chiou CS, Lu MC, Lai YC. Two ST11 Klebsiella pneumoniae strains exacerbate colorectal tumorigenesis in a colitis-associated mouse model. Gut Microbes 2021;13:1980348. [PMID: 34606408 DOI: 10.1080/19490976.2021.1980348] [Reference Citation Analysis]
43 Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res 2021;163:105362. [PMID: 33285231 DOI: 10.1016/j.phrs.2020.105362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yuan B, Ma B, Yu J, Meng Q, Du T, Li H, Zhu Y, Sun Z, Ma S, Song C. Fecal Bacteria as Non-Invasive Biomarkers for Colorectal Adenocarcinoma. Front Oncol 2021;11:664321. [PMID: 34447694 DOI: 10.3389/fonc.2021.664321] [Reference Citation Analysis]
45 Rezasoltani S, Ahmadi Bashirzadeh D, Nazemalhosseini Mojarad E, Asadzadeh Aghdaei H, Norouzinia M, Shahrokh S. Signature of Gut Microbiome by Conventional and Advanced Analysis Techniques: Advantages and Disadvantages. Middle East J Dig Dis 2020;12:5-11. [PMID: 32082515 DOI: 10.15171/mejdd.2020.157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wang H, Yan Y, Yi X, Duan Y, Wang J, Li S, Luo L, Huang T, Inglis B, Li X, Ji W, Tan T, Si W. Histopathological Features and Composition of Gut Microbiota in Rhesus Monkey of Alcoholic Liver Disease.Front Microbiol. 2019;10:165. [PMID: 30800107 DOI: 10.3389/fmicb.2019.00165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
47 Yang R, Yin D, Yang D, Liu X, Zhou Q, Pan Y, Li J, Li S. Xinnaokang improves cecal microbiota and lipid metabolism to target atherosclerosis. Lett Appl Microbiol 2021;73:779-92. [PMID: 34596907 DOI: 10.1111/lam.13573] [Reference Citation Analysis]
48 Lee BM, Park JW, Jo JH, Oh B, Chung G. Comparative analysis of the oral microbiome of burning mouth syndrome patients. J Oral Microbiol 2022;14:2052632. [PMID: 35341209 DOI: 10.1080/20002297.2022.2052632] [Reference Citation Analysis]
49 Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, Monroy-Ramírez HC, Galicia-Moreno M, García-Bañuelos J, Santos A, Armendariz-Borunda J. Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge. Cells 2021;10:629. [PMID: 33809061 DOI: 10.3390/cells10030629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
50 Sanborn V, Gunstad J. The Potential Mediation of the Effects of Physical Activity on Cognitive Function by the Gut Microbiome. Geriatrics (Basel) 2020;5:E63. [PMID: 32992812 DOI: 10.3390/geriatrics5040063] [Reference Citation Analysis]
51 Sawicka-Smiarowska E, Bondarczuk K, Bauer W, Niemira M, Szalkowska A, Raczkowska J, Kwasniewski M, Tarasiuk E, Dubatowka M, Lapinska M, Szpakowicz M, Stachurska Z, Szpakowicz A, Sowa P, Raczkowski A, Kondraciuk M, Gierej M, Motyka J, Jamiolkowski J, Bondarczuk M, Chlabicz M, Bucko J, Kozuch M, Dobrzycki S, Bychowski J, Musial WJ, Godlewski A, Ciborowski M, Gyenesei A, Kretowski A, Kaminski KA. Gut Microbiome in Chronic Coronary Syndrome Patients. J Clin Med 2021;10:5074. [PMID: 34768594 DOI: 10.3390/jcm10215074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bello-Gil D, Audebert C, Olivera-Ardid S, Pérez-Cruz M, Even G, Khasbiullina N, Gantois N, Shilova N, Merlin S, Costa C, Bovin N, Mañez R. The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota. Front Immunol 2019;10:342. [PMID: 30891034 DOI: 10.3389/fimmu.2019.00342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
53 Mousa WK, Chehadeh F, Husband S. Recent Advances in Understanding the Structure and Function of the Human Microbiome. Front Microbiol 2022;13:825338. [DOI: 10.3389/fmicb.2022.825338] [Reference Citation Analysis]
54 Bryniarski MA, Hamarneh F, Yacoub R. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease. Exp Biol Med (Maywood) 2019;244:514-25. [PMID: 30682892 DOI: 10.1177/1535370219826526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
55 Guo H, Ma C, Zheng W, Luo Y, Li C, Li X, Ma X, Feng C, Zhang T, Han Y, Luo Z, Zhan Y, Li R, Wang L, Jiang J. Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters. Adv Funct Mater 2019;29:1808197. [DOI: 10.1002/adfm.201808197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
56 Herrema H, Nieuwdorp M, Groen AK. Microbiome and Cardiovascular Disease. Berlin: Springer Berlin Heidelberg; 2020. [DOI: 10.1007/164_2020_356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
57 Mantziaris V, Kolios G. Gut Microbiota, Atherosclerosis, and Therapeutic Targets. Crit Pathw Cardiol 2019;18:139-42. [PMID: 31348074 DOI: 10.1097/HPC.0000000000000187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Mao G, Li S, Orfila C, Shen X, Zhou S, Linhardt RJ, Ye X, Chen S. Depolymerized RG-I-enriched pectin from citrus segment membranes modulates gut microbiota, increases SCFA production, and promotes the growth of Bifidobacterium spp., Lactobacillus spp. and Faecalibaculum spp. Food Funct 2019;10:7828-43. [PMID: 31778135 DOI: 10.1039/c9fo01534e] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 9.5] [Reference Citation Analysis]
59 Yu W, Gao D, Jin W, Wang Z, Li Y, Peng X, Cong Y, Li C, Zhao A, Liu S, Qi S. Intestinal Flora Dysbiosis Aggravates Cognitive Dysfunction Associated With Neuroinflammation in Heart Failure. J Card Fail 2020;26:885-94. [PMID: 32105821 DOI: 10.1016/j.cardfail.2020.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zheng YY, Wu TT, Guo QQ, Chen Y, Ma X, Ma YT, Zhang JY, Xie X. Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease. Atherosclerosis 2021;328:1-10. [PMID: 34052667 DOI: 10.1016/j.atherosclerosis.2021.04.012] [Reference Citation Analysis]
61 Wang K, Dong Y, Liu J, Qian L, Wang T, Gao X, Wang K, Zhou L. Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases. Oxid Med Cell Longev 2020;2020:5860356. [PMID: 33282111 DOI: 10.1155/2020/5860356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Bendiks ZA, Knudsen KEB, Keenan MJ, Marco ML. Conserved and variable responses of the gut microbiome to resistant starch type 2. Nutr Res 2020;77:12-28. [PMID: 32251948 DOI: 10.1016/j.nutres.2020.02.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
63 Wang ZQ, Zhang L, Zheng H, Guo WB, Gao Y, Zhao YF, Liu DW, Zhou MG, Li M. Burden and trend of ischemic heart disease and colorectal cancer attributable to a diet low in fiber in China, 1990-2017: findings from the Global Burden of Disease Study 2017. Eur J Nutr 2021. [PMID: 33852070 DOI: 10.1007/s00394-021-02556-6] [Reference Citation Analysis]
64 Han Y, Gong Z, Sun G, Xu J, Qi C, Sun W, Jiang H, Cao P, Ju H. Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction. Front Microbiol 2021;12:680101. [PMID: 34295318 DOI: 10.3389/fmicb.2021.680101] [Reference Citation Analysis]
65 Tam I, Liu PH, Ma W, Cao Y, Jovani M, Wu K, Rimm EB, Strate LL, Giovannucci EL, Chan AT. History of Diverticulitis and Risk of Incident Cardiovascular Disease in Men: A Cohort Study. Dig Dis Sci 2021. [PMID: 33770332 DOI: 10.1007/s10620-021-06949-9] [Reference Citation Analysis]
66 Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 2020;13:637-56. [PMID: 31984651 DOI: 10.1111/1751-7915.13524] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
67 Yan S, Yin XM. Gut microbiome in liver pathophysiology and cholestatic liver disease. Liver Res 2021;5:151-63. [PMID: 35355516 DOI: 10.1016/j.livres.2021.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Zhang C, Franklin CL, Ericsson AC. Consideration of Gut Microbiome in Murine Models of Diseases. Microorganisms 2021;9:1062. [PMID: 34068994 DOI: 10.3390/microorganisms9051062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kirichenko TV, Markina YV, Sukhorukov VN, Khotina VA, Wu WK, Orekhov AN. A Novel Insight at Atherogenesis: The Role of Microbiome. Front Cell Dev Biol 2020;8:586189. [PMID: 33072766 DOI: 10.3389/fcell.2020.586189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Panyod S, Wu WK, Chen PC, Chong KV, Yang YT, Chuang HL, Chen CC, Chen RA, Liu PY, Chung CH, Huang HS, Lin AY, Shen TD, Yang KC, Huang TF, Hsu CC, Ho CT, Kao HL, Orekhov AN, Wu MS, Sheen LY. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation. NPJ Biofilms Microbiomes 2022;8:4. [PMID: 35087050 DOI: 10.1038/s41522-022-00266-3] [Reference Citation Analysis]
71 Zhang Y, Xu J, Wang X, Ren X, Liu Y. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. BMC Genomics 2019;20:862. [PMID: 31726978 DOI: 10.1186/s12864-019-6251-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
72 Anto L, Blesso CN. Interplay Between Diet, the Gut Microbiome, and Atherosclerosis: Role of Dysbiosis and Microbial Metabolites on Inflammation and Disordered Lipid Metabolism. The Journal of Nutritional Biochemistry 2022. [DOI: 10.1016/j.jnutbio.2022.108991] [Reference Citation Analysis]
73 Zagoskin PP, Erlykina EI. Bile Acids as a New Type of Steroid Hormones Regulating Nonspecific Energy Expenditure of the Body (Review). Sovrem Tekhnologii Med 2021;12:114-27. [PMID: 34796012 DOI: 10.17691/stm2020.12.5.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Chen H, Gong J, Xing K, Liu M, Ren H, Luo J. Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment. Front Med 2022;8:742394. [DOI: 10.3389/fmed.2021.742394] [Reference Citation Analysis]
75 Rath S, Rud T, Karch A, Pieper DH, Vital M. Pathogenic functions of host microbiota. Microbiome 2018;6:174. [PMID: 30266099 DOI: 10.1186/s40168-018-0542-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
76 Zhao L, Zhang X, Zhu L, Geng S, Guo K. Effectiveness and safety of Adalimumab in psoriasis and its influence on gut microbiome. Microb Pathog 2021;162:105308. [PMID: 34843923 DOI: 10.1016/j.micpath.2021.105308] [Reference Citation Analysis]
77 Restini CBA, Fink GD, Watts SW. Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved? Pharmacol Res 2021;163:105273. [PMID: 33197599 DOI: 10.1016/j.phrs.2020.105273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
78 Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, Kalavagunta PK, Liao J, Jin L, Shang J, Li J. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome 2019;7:9. [PMID: 30674356 DOI: 10.1186/s40168-019-0628-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 22.0] [Reference Citation Analysis]
79 Chen L, Ishigami T, Doi H, Arakawa K, Tamura K. The Types and Proportions of Commensal Microbiota Have a Predictive Value in Coronary Heart Disease. J Clin Med 2021;10:3120. [PMID: 34300286 DOI: 10.3390/jcm10143120] [Reference Citation Analysis]
80 Fromentin S, Forslund SK, Chechi K, Aron-Wisnewsky J, Chakaroun R, Nielsen T, Tremaroli V, Ji B, Prifti E, Myridakis A, Chilloux J, Andrikopoulos P, Fan Y, Olanipekun MT, Alves R, Adiouch S, Bar N, Talmor-Barkan Y, Belda E, Caesar R, Coelho LP, Falony G, Fellahi S, Galan P, Galleron N, Helft G, Hoyles L, Isnard R, Le Chatelier E, Julienne H, Olsson L, Pedersen HK, Pons N, Quinquis B, Rouault C, Roume H, Salem JE, Schmidt TSB, Vieira-Silva S, Li P, Zimmermann-Kogadeeva M, Lewinter C, Søndertoft NB, Hansen TH, Gauguier D, Gøtze JP, Køber L, Kornowski R, Vestergaard H, Hansen T, Zucker JD, Hercberg S, Letunic I, Bäckhed F, Oppert JM, Nielsen J, Raes J, Bork P, Stumvoll M, Segal E, Clément K, Dumas ME, Ehrlich SD, Pedersen O. Microbiome and metabolome features of the cardiometabolic disease spectrum. Nat Med 2022;28:303-14. [PMID: 35177860 DOI: 10.1038/s41591-022-01688-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
81 Daeschlein G, Hinz P, Kiefer T, Jünger M. [Role of the microbiome in chronic wounds]. Hautarzt 2019;70:422-31. [PMID: 31134288 DOI: 10.1007/s00105-019-4425-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Luo G, Li B, Yang C, Wang Y, Bian X, Li W, Liu F, Huo G. Major Traditional Probiotics: Comparative Genomic Analyses and Roles in Gut Microbiome of Eight Cohorts. Front Microbiol 2019;10:712. [PMID: 31024492 DOI: 10.3389/fmicb.2019.00712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
83 Hathaway-Schrader JD, Steinkamp HM, Chavez MB, Poulides NA, Kirkpatrick JE, Chew ME, Huang E, Alekseyenko AV, Aguirre JI, Novince CM. Antibiotic Perturbation of Gut Microbiota Dysregulates Osteoimmune Cross Talk in Postpubertal Skeletal Development. Am J Pathol 2019;189:370-90. [PMID: 30660331 DOI: 10.1016/j.ajpath.2018.10.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
84 Xiang Z, Zhu H, Yang B, Fan H, Guo J, Liu J, Kong Q, Teng Q, Shang H, Su L, Qin C. A glance at the gut microbiota of five experimental animal species through fecal samples. Sci Rep 2020;10:16628. [PMID: 33024229 DOI: 10.1038/s41598-020-73985-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Zheng N, Li SH, Dong B, Sun W, Li HR, Zhang YL, Li P, Fang ZW, Chen CM, Han XY, Li B, Zhang SY, Xu M, Zhang GX, Xin Y, Ma YF, Wan XY, Yan QL. Comparison of the gut microbiota of short-term and long-term medical workers and non-medical controls: a cross-sectional analysis. Clin Microbiol Infect 2021;27:1285-92. [PMID: 33160036 DOI: 10.1016/j.cmi.2020.10.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Park SC, Park IH, Lee JS, Park SM, Kang SH, Hong SM, Byun SH, Jung YG, Hong SJ. Microbiome of Unilateral Chronic Rhinosinusitis: A Controlled Paired Analysis. Int J Environ Res Public Health 2021;18:9878. [PMID: 34574801 DOI: 10.3390/ijerph18189878] [Reference Citation Analysis]
87 Kushugulova A, Forslund SK, Costea PI, Kozhakhmetov S, Khassenbekova Z, Urazova M, Nurgozhin T, Zhumadilov Z, Benberin V, Driessen M, Hercog R, Voigt AY, Benes V, Kandels-Lewis S, Sunagawa S, Letunic I, Bork P. Metagenomic analysis of gut microbial communities from a Central Asian population. BMJ Open 2018;8:e021682. [PMID: 30056386 DOI: 10.1136/bmjopen-2018-021682] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
88 Wang J, Shan S, Lyu A, Wan Y, Zhang J. Helianthus Annuus L. Alleviates High-Fat Diet Induced Atherosclerosis by Regulating Intestinal Microbiota, Inhibiting Inflammation and Restraining Oxidative Stress. Am J Chin Med 2021;49:1683-701. [PMID: 34521318 DOI: 10.1142/S0192415X21500798] [Reference Citation Analysis]
89 Lv Z, Shan X, Tu Q, Wang J, Chen J, Yang Y. Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE−/− mice. Biomedicine & Pharmacotherapy 2021;134:111100. [DOI: 10.1016/j.biopha.2020.111100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
90 Riaz Rajoka MS, Zhao H, Li N, Lu Y, Lian Z, Shao D, Jin M, Li Q, Zhao L, Shi J. Origination, change, and modulation of geriatric disease-related gut microbiota during life. Appl Microbiol Biotechnol 2018;102:8275-89. [PMID: 30066188 DOI: 10.1007/s00253-018-9264-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
91 Shao L, Liao J, Qian J, Chen W, Fan X. MetaGeneBank: a standardized database to study deep sequenced metagenomic data from human fecal specimen. BMC Microbiol 2021;21:263. [PMID: 34592929 DOI: 10.1186/s12866-021-02321-z] [Reference Citation Analysis]
92 Qin Y, Wade PA. Crosstalk between the microbiome and epigenome: messages from bugs. J Biochem 2018;163:105-12. [PMID: 29161429 DOI: 10.1093/jb/mvx080] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 22.0] [Reference Citation Analysis]
93 Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA, Leeming E, Gibson R, Le Roy C, Khatib HA, Francis L, Mazidi M, Mompeo O, Valles-Colomer M, Tett A, Beghini F, Dubois L, Bazzani D, Thomas AM, Mirzayi C, Khleborodova A, Oh S, Hine R, Bonnett C, Capdevila J, Danzanvilliers S, Giordano F, Geistlinger L, Waldron L, Davies R, Hadjigeorgiou G, Wolf J, Ordovás JM, Gardner C, Franks PW, Chan AT, Huttenhower C, Spector TD, Segata N. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med 2021;27:321-32. [PMID: 33432175 DOI: 10.1038/s41591-020-01183-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 44.0] [Reference Citation Analysis]
94 Tsai HJ, Tsai WC, Hung WC, Hung WW, Chang CC, Dai CY, Tsai YC. Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus. Nutrients 2021;13:2679. [PMID: 34444839 DOI: 10.3390/nu13082679] [Reference Citation Analysis]
95 Guzmán-Castañeda SJ, Ortega-Vega EL, de la Cuesta-Zuluaga J, Velásquez-Mejía EP, Rojas W, Bedoya G, Escobar JS. Gut microbiota composition explains more variance in the host cardiometabolic risk than genetic ancestry. Gut Microbes 2020;11:191-204. [PMID: 31311405 DOI: 10.1080/19490976.2019.1634416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
96 Shimizu Y. Gut microbiota in common elderly diseases affecting activities of daily living. World J Gastroenterol 2018; 24(42): 4750-4758 [PMID: 30479462 DOI: 10.3748/wjg.v24.i42.4750] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
97 Tsai YT, Ruan JW, Chang CS, Ko ML, Chou HC, Lin CC, Lin CM, Huang CT, Wei YS, Liao EC, Chen HY, Lin LH, Lin MW, Kao CY, Chan HL. Proteomic and microbial assessments on the effect of Antrodia cinnamomea in C57BL/6 mice. Arch Biochem Biophys 2021;713:109058. [PMID: 34627749 DOI: 10.1016/j.abb.2021.109058] [Reference Citation Analysis]
98 Murphy K, O'Donovan AN, Caplice NM, Ross RP, Stanton C. Exploring the Gut Microbiota and Cardiovascular Disease. Metabolites 2021;11:493. [PMID: 34436434 DOI: 10.3390/metabo11080493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Sanchis-Gomar F, Lavie CJ, Marín J, Perez-Quilis C, Eijsvogels TMH, O'Keefe JH, Perez MV, Blair SN. Exercise Effects On Cardiovascular Disease: From Basic Aspects To Clinical Evidence. Cardiovasc Res 2021:cvab272. [PMID: 34478520 DOI: 10.1093/cvr/cvab272] [Reference Citation Analysis]
100 Lo Gullo A, Giuffrida C, Morace C, Squadrito G, Magnano San Lio P, Ricciardi L, Salvarani C, Mandraffino G. Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review. Front Med 2022;9:824630. [DOI: 10.3389/fmed.2022.824630] [Reference Citation Analysis]
101 Yu B, Jin L, Chen Z, Nie W, Chen L, Ma Y, Chen H, Wu Y, Ma Y, Chen J, Han F. The gut microbiome in microscopic polyangiitis with kidney involvement: common and unique alterations, clinical association and values for disease diagnosis and outcome prediction. Ann Transl Med 2021;9:1286. [PMID: 34532423 DOI: 10.21037/atm-21-1315] [Reference Citation Analysis]
102 Fei N, Bernabé BP, Lie L, Baghdan D, Bedu-Addo K, Plange-Rhule J, Forrester TE, Lambert EV, Bovet P, Gottel N, Riesen W, Korte W, Luke A, Kliethermes SA, Layden BT, Gilbert JA, Dugas LR. The human microbiota is associated with cardiometabolic risk across the epidemiologic transition. PLoS One 2019;14:e0215262. [PMID: 31339887 DOI: 10.1371/journal.pone.0215262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
103 Ma J, Li H. The Role of Gut Microbiota in Atherosclerosis and Hypertension. Front Pharmacol 2018;9:1082. [PMID: 30319417 DOI: 10.3389/fphar.2018.01082] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 23.0] [Reference Citation Analysis]
104 Zhang J, Zuo K, Fang C, Yin X, Liu X, Zhong J, Li K, Li J, Xu L, Yang X. Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation. BMC Genomics 2021;22:634. [PMID: 34465304 DOI: 10.1186/s12864-021-07944-0] [Reference Citation Analysis]
105 Wan S, Nie Y, Zhang Y, Huang C, Zhu X. Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice. Front Cell Infect Microbiol 2020;10:18. [PMID: 32083022 DOI: 10.3389/fcimb.2020.00018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Wan SZ, Liu C, Huang CK, Luo FY, Zhu X. Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice. Front Pharmacol 2019;10:1321. [PMID: 31736766 DOI: 10.3389/fphar.2019.01321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
107 Cheng TY, Li JX, Chen JY, Chen PY, Ma LR, Zhang GL, Yan PY. Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease. Chin Med 2021;16:108. [PMID: 34686199 DOI: 10.1186/s13020-021-00516-0] [Reference Citation Analysis]
108 Kitten AK, Ryan L, Lee GC, Flores BE, Reveles KR. Gut microbiome differences among Mexican Americans with and without type 2 diabetes mellitus. PLoS One 2021;16:e0251245. [PMID: 33983982 DOI: 10.1371/journal.pone.0251245] [Reference Citation Analysis]
109 Ma S, Zhang F, Zhou F, Li H, Ge W, Gan R, Nie H, Li B, Wang Y, Wu M, Li D, Wang D, Wang Z, You Y, Huang Z. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct Target Ther 2021;6:191. [PMID: 33986253 DOI: 10.1038/s41392-021-00614-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
110 Miclotte L, De Paepe K, Rymenans L, Callewaert C, Raes J, Rajkovic A, Van Camp J, Van de Wiele T. Dietary Emulsifiers Alter Composition and Activity of the Human Gut Microbiota in vitro, Irrespective of Chemical or Natural Emulsifier Origin. Front Microbiol 2020;11:577474. [PMID: 33250870 DOI: 10.3389/fmicb.2020.577474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
111 Keller C, Wei P, Wancewicz B, Cross TL, Rey FE, Li L. Extraction optimization for combined metabolomics, peptidomics, and proteomics analysis of gut microbiota samples. J Mass Spectrom 2021;56:e4625. [PMID: 32885503 DOI: 10.1002/jms.4625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Sharma R. Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities. Probiotics Antimicrob Proteins 2022. [PMID: 34985682 DOI: 10.1007/s12602-021-09903-3] [Reference Citation Analysis]
113 Lin Y, Wang ZY, Wang MJ, Jiang ZM, Qin YQ, Huang TQ, Yu S, Liang HT, Liu EH. Baicalin attenuate diet-induced metabolic syndrome by improving abnormal metabolism and gut microbiota. Eur J Pharmacol 2022;:174996. [PMID: 35513018 DOI: 10.1016/j.ejphar.2022.174996] [Reference Citation Analysis]
114 Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR. "Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome? Photobiomodul Photomed Laser Surg 2019;37:681-93. [PMID: 31596658 DOI: 10.1089/photob.2019.4628] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
115 Tonomura S, Ihara M, Friedland RP. Microbiota in cerebrovascular disease: A key player and future therapeutic target. J Cereb Blood Flow Metab 2020;40:1368-80. [PMID: 32312168 DOI: 10.1177/0271678X20918031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
116 Gao Q, Han ZY, Tian DF, Liu GL, Wang ZY, Lin JF, Chang Z, Zhang DD, Xie YZ, Sun YK, Yao XW, Ma DY. Xinglou Chengqi Decoction improves neurological function in experimental stroke mice as evidenced by gut microbiota analysis and network pharmacology. Chin J Nat Med 2021;19:881-99. [PMID: 34961587 DOI: 10.1016/S1875-5364(21)60079-1] [Reference Citation Analysis]
117 Xu J, Yang Y. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases. Gut Microbes 2021;13:1936379. [PMID: 34170211 DOI: 10.1080/19490976.2021.1936379] [Reference Citation Analysis]
118 Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71. [PMID: 32887946 DOI: 10.1038/s41579-020-0433-9] [Cited by in Crossref: 125] [Cited by in F6Publishing: 117] [Article Influence: 62.5] [Reference Citation Analysis]
119 Zhong X, Powell C, Phillips CM, Millar SR, Carson BP, Dowd KP, Perry IJ, Kearney PM, Harrington JM, O'Toole PW, Donnelly AE. The Influence of Different Physical Activity Behaviours on the Gut Microbiota of Older Irish Adults. J Nutr Health Aging 2021;25:854-61. [PMID: 34409962 DOI: 10.1007/s12603-021-1630-6] [Reference Citation Analysis]
120 Wu F, Yang L, Islam MT, Jasmine F, Kibriya MG, Nahar J, Barmon B, Parvez F, Sarwar G, Ahmed A, Eunus M, Islam T, Slavkovich V, Hu J, Li H, Graziano JH, Pei Z, Ahsan H, Chen Y. The role of gut microbiome and its interaction with arsenic exposure in carotid intima-media thickness in a Bangladesh population. Environ Int 2019;123:104-13. [PMID: 30503971 DOI: 10.1016/j.envint.2018.11.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
121 Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients 2020;12:E1434. [PMID: 32429195 DOI: 10.3390/nu12051434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
122 Wang M, Chen G, Chen D, Ye H, Sun Y, Zeng X, Liu Z. Purified fraction of polysaccharides from Fuzhuan brick tea modulates the composition and metabolism of gut microbiota in anaerobic fermentation in vitro. Int J Biol Macromol 2019;140:858-70. [PMID: 31446105 DOI: 10.1016/j.ijbiomac.2019.08.187] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
123 Chin VK, Yong VC, Chong PP, Amin Nordin S, Basir R, Abdullah M. Mycobiome in the Gut: A Multiperspective Review. Mediators Inflamm 2020;2020:9560684. [PMID: 32322167 DOI: 10.1155/2020/9560684] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
124 Anselmi G, Gagliardi L, Egidi G, Leone S, Gasbarrini A, Miggiano GAD, Galiuto L. Gut Microbiota and Cardiovascular Diseases: A Critical Review. Cardiol Rev 2021;29:195-204. [PMID: 32639240 DOI: 10.1097/CRD.0000000000000327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol 2021;72:636-68. [PMID: 32472555 DOI: 10.1111/lam.13333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
126 Liu S, Zhao W, Liu X, Cheng L. Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target. FASEB J. 2020;34:14166-14181. [PMID: 32939880 DOI: 10.1096/fj.202000622r] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
127 Kalinkovich A, Gabdulina G, Livshits G. Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis. Immunol Res 2018;66:696-709. [DOI: 10.1007/s12026-018-9048-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
128 Evenepoel P, Dejongh S, Verbeke K, Meijers B. The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease. Toxins (Basel) 2020;12:E285. [PMID: 32365480 DOI: 10.3390/toxins12050285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
129 Tibbs TN, Lopez LR, Arthur JC. The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging. Microb Cell 2019;6:324-34. [PMID: 31403049 DOI: 10.15698/mic2019.08.685] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
130 Konop M, Rybka M, Waraksa E, Laskowska AK, Nowiński A, Grzywacz T, Karwowski WJ, Drapała A, Kłodzińska EM. Electrophoretic Determination of Trimethylamine (TMA) in Biological Samples as a Novel Potential Biomarker of Cardiovascular Diseases Methodological Approach. Int J Environ Res Public Health 2021;18:12318. [PMID: 34886043 DOI: 10.3390/ijerph182312318] [Reference Citation Analysis]
131 Liu Z, Li J, Liu H, Tang Y, Zhan Q, Lai W, Ao L, Meng X, Ren H, Xu D, Zeng Q. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease. Atherosclerosis 2019;284:121-8. [PMID: 30897381 DOI: 10.1016/j.atherosclerosis.2018.11.038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
132 Sharma PV, Thaiss CA. Host-Microbiome Interactions in the Era of Single-Cell Biology. Front Cell Infect Microbiol 2020;10:569070. [PMID: 33163417 DOI: 10.3389/fcimb.2020.569070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
133 Kim J, Lee JY, Ham NS, Oh EH, Chang HS, Park H, Do YS, Hwang SW, Yang DH, Choe JW, Byeon JS. Association Between Carotid Ultrasonography Findings and Colorectal Adenoma in Asymptomatic Adults. Dig Dis Sci 2020;65:1816-28. [PMID: 31624981 DOI: 10.1007/s10620-019-05899-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
134 Rosa BA, Mihindukulasuriya K, Hallsworth-Pepin K, Wollam A, Martin J, Snowden C, Dunne WM Jr, Weinstock GM, Burnham CA, Mitreva M. Improving Characterization of Understudied Human Microbiomes Using Targeted Phylogenetics. mSystems 2020;5:e00096-20. [PMID: 32098835 DOI: 10.1128/mSystems.00096-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Heianza Y, Ma W, DiDonato JA, Sun Q, Rimm EB, Hu FB, Rexrode KM, Manson JE, Qi L. Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk. J Am Coll Cardiol 2020;75:763-72. [PMID: 32081286 DOI: 10.1016/j.jacc.2019.11.060] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
136 Farràs M, Martinez-Gili L, Portune K, Arranz S, Frost G, Tondo M, Blanco-Vaca F. Modulation of the Gut Microbiota by Olive Oil Phenolic Compounds: Implications for Lipid Metabolism, Immune System, and Obesity. Nutrients 2020;12:E2200. [PMID: 32718098 DOI: 10.3390/nu12082200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
137 Maifeld A, Bartolomaeus H, Löber U, Avery EG, Steckhan N, Markó L, Wilck N, Hamad I, Šušnjar U, Mähler A, Hohmann C, Chen CY, Cramer H, Dobos G, Lesker TR, Strowig T, Dechend R, Bzdok D, Kleinewietfeld M, Michalsen A, Müller DN, Forslund SK. Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients. Nat Commun 2021;12:1970. [PMID: 33785752 DOI: 10.1038/s41467-021-22097-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
138 Cortés-Martín A, Iglesias-Aguirre CE, Meoro A, Selma MV, Espín JC. There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication. Microorganisms 2020;8:E416. [PMID: 32183480 DOI: 10.3390/microorganisms8030416] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
139 Gebru YA, Choi MR, Raja G, Gupta H, Sharma SP, Choi YR, Kim HS, Yoon SJ, Kim DJ, Suk KT. Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis. Microorganisms 2021;9:296. [PMID: 33535703 DOI: 10.3390/microorganisms9020296] [Reference Citation Analysis]
140 Ziegler M, Wallert M, Lorkowski S, Peter K. Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy? Antioxidants (Basel) 2020;9:E935. [PMID: 33003543 DOI: 10.3390/antiox9100935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
141 Yang J, Yang Y, Ishii M, Nagata M, Aw W, Obana N, Tomita M, Nomura N, Fukuda S. Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms? Microbes Environ 2020;35. [PMID: 32624527 DOI: 10.1264/jsme2.ME20037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Zhang B, Wang X, Xia R, Li C. Gut microbiota in coronary artery disease: a friend or foe? Biosci Rep 2020;40:BSR20200454. [PMID: 32352513 DOI: 10.1042/BSR20200454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
143 Lindskog Jonsson A, Caesar R, Akrami R, Reinhardt C, Fåk Hållenius F, Borén J, Bäckhed F. Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe-/- Mice. Arterioscler Thromb Vasc Biol 2018;38:2318-26. [PMID: 29903735 DOI: 10.1161/ATVBAHA.118.311233] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 20.7] [Reference Citation Analysis]
144 Velasquez MT, Centron P, Barrows I, Dwivedi R, Raj DS. Gut Microbiota and Cardiovascular Uremic Toxicities. Toxins (Basel) 2018;10:E287. [PMID: 29997362 DOI: 10.3390/toxins10070287] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
145 Nie X, Chen J, Ma X, Ni Y, Shen Y, Yu H, Panagiotou G, Bao Y. A metagenome-wide association study of gut microbiome and visceral fat accumulation. Comput Struct Biotechnol J 2020;18:2596-609. [PMID: 33033580 DOI: 10.1016/j.csbj.2020.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
146 Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R. Role of gut microbiota in cardiovascular diseases. World J Cardiol 2020; 12(4): 110-122 [PMID: 32431782 DOI: 10.4330/wjc.v12.i4.110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
147 Macke L, Schulz C, Koletzko L, Malfertheiner P. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies. Aliment Pharmacol Ther. 2020;51:505-526. [PMID: 31990420 DOI: 10.1111/apt.15604] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
148 Chu Y, Sun S, Huang Y, Gao Q, Xie X, Wang P, Li J, Liang L, He X, Jiang Y, Wang M, Yang J, Chen X, Zhou C, Zhao Y, Ding F, Zhang Y, Wu X, Bai X, Wu J, Wei X, Chen X, Yue Z, Fang X, Huang Q, Wang Z, Huang R. Metagenomic analysis revealed the potential role of gut microbiome in gout. NPJ Biofilms Microbiomes 2021;7:66. [PMID: 34373464 DOI: 10.1038/s41522-021-00235-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Khan S, Sharaf M, Ahmed I, Khan TU, Shabana S, Arif M, Kazmi SSUH, Liu C. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34658307 DOI: 10.1080/14787210.2022.1990041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, Pang H, Jiang L, Qiu B, Chen X, Zhang Y, Ma Y, Tang S, Li H, Feng S, Zhang S, Zhang C. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome 2019;7:68. [PMID: 31027508 DOI: 10.1186/s40168-019-0683-9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 20.3] [Reference Citation Analysis]
151 Xu M, Lv C, Wang H, Lu Q, Ye M, Zhu X, Liu R. Peanut skin extract ameliorates high-fat diet-induced atherosclerosis by regulating lipid metabolism, inflammation reaction and gut microbiota in ApoE−/− mice. Food Research International 2022;154:111014. [DOI: 10.1016/j.foodres.2022.111014] [Reference Citation Analysis]
152 Oniszczuk A, Oniszczuk T, Gancarz M, Szymańska J. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases. Molecules 2021;26:1172. [PMID: 33671813 DOI: 10.3390/molecules26041172] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
153 de Groot P, Scheithauer T, Bakker GJ, Prodan A, Levin E, Khan MT, Herrema H, Ackermans M, Serlie MJM, de Brauw M, Levels JHM, Sales A, Gerdes VE, Ståhlman M, Schimmel AWM, Dallinga-Thie G, Bergman JJ, Holleman F, Hoekstra JBL, Groen A, Bäckhed F, Nieuwdorp M. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Gut 2020;69:502-12. [PMID: 31147381 DOI: 10.1136/gutjnl-2019-318320] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 22.3] [Reference Citation Analysis]
154 Evans LW, Athukorala M, Martinez-Guryn K, Ferguson BS. The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases. Int J Mol Sci 2020;21:E4006. [PMID: 32503339 DOI: 10.3390/ijms21114006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Liu RT, Rowan-Nash AD, Sheehan AE, Walsh RFL, Sanzari CM, Korry BJ, Belenky P. Reductions in anti-inflammatory gut bacteria are associated with depression in a sample of young adults. Brain Behav Immun 2020;88:308-24. [PMID: 32229219 DOI: 10.1016/j.bbi.2020.03.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
156 Fredensborg BL, Fossdal Í Kálvalíð I, Johannesen TB, Stensvold CR, Nielsen HV, Kapel CMO. Parasites modulate the gut-microbiome in insects: A proof-of-concept study. PLoS One 2020;15:e0227561. [PMID: 31935259 DOI: 10.1371/journal.pone.0227561] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
157 Wang Q, Yang F, Jia H. Mining the Microbiome for Drug Targets. Methods Enzymol 2018;610:59-72. [PMID: 30390805 DOI: 10.1016/bs.mie.2018.09.014] [Reference Citation Analysis]
158 Zununi Vahed S, Barzegari A, Zuluaga M, Letourneur D, Pavon-djavid G. Myocardial infarction and gut microbiota: An incidental connection. Pharmacological Research 2018;129:308-17. [DOI: 10.1016/j.phrs.2017.11.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
159 Joshi A, Rienks M, Theofilatos K, Mayr M. Systems biology in cardiovascular disease: a multiomics approach. Nat Rev Cardiol 2021;18:313-30. [PMID: 33340009 DOI: 10.1038/s41569-020-00477-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
160 Kurilenko N, Fatkhullina AR, Mazitova A, Koltsova EK. Act Locally, Act Globally-Microbiota, Barriers, and Cytokines in Atherosclerosis. Cells 2021;10:348. [PMID: 33562334 DOI: 10.3390/cells10020348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
161 Wang Y, Liu F, Zhang G, Su Y, Sun X, Chen Q, Wang C, Fu H, He Y, Zhu X, Liu X, Lv M, Zhao X, Zhao X, Li Y, Wang Q, Huang X, Zhang X. Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia. Sci China Life Sci 2021;64:766-83. [PMID: 32857289 DOI: 10.1007/s11427-020-1788-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Heianza Y, Ma W, Li X, Cao Y, Chan AT, Rimm EB, Hu FB, Rexrode KM, Manson JE, Qi L. Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality: Prospective Cohort Study. Circ Res 2020;126:364-73. [PMID: 31842690 DOI: 10.1161/CIRCRESAHA.119.315279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
163 Bashiardes S, Abdeen SK, Elinav E. Personalized Nutrition: Are We There Yet? J Pediatr Gastroenterol Nutr 2019;69:633-8. [PMID: 31765333 DOI: 10.1097/MPG.0000000000002491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
164 Vakili D, Radenkovic D, Chawla S, Bhatt DL. Panomics: New Databases for Advancing Cardiology. Front Cardiovasc Med 2021;8:587768. [PMID: 34041278 DOI: 10.3389/fcvm.2021.587768] [Reference Citation Analysis]
165 Li Q, Peng W, Wu J, Wang X, Ren Y, Li H, Peng Y, Tang X, Fu X. Autoinducer-2 of gut microbiota, a potential novel marker for human colorectal cancer, is associated with the activation of TNFSF9 signaling in macrophages. Oncoimmunology 2019;8:e1626192. [PMID: 31646072 DOI: 10.1080/2162402X.2019.1626192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
166 Du X, Liu J, Xue Y, Kong X, Lv C, Li Z, Huang Y, Wang B. Alteration of gut microbial profile in patients with diabetic nephropathy. Endocrine 2021;73:71-84. [PMID: 33905112 DOI: 10.1007/s12020-021-02721-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Tuerhongjiang G, Guo M, Qiao X, Lou B, Wang C, Wu H, Wu Y, Yuan Z, She J. Interplay Between Gut Microbiota and Amino Acid Metabolism in Heart Failure. Front Cardiovasc Med 2021;8:752241. [PMID: 34746265 DOI: 10.3389/fcvm.2021.752241] [Reference Citation Analysis]
168 Yang X, Zhang X, Yang W, Yu H, He Q, Xu H, Li S, Shang Z, Gao X, Wang Y, Tong Q. Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ. Front Endocrinol (Lausanne) 2021;12:749125. [PMID: 34552566 DOI: 10.3389/fendo.2021.749125] [Reference Citation Analysis]
169 Yoshida N, Sasaki K, Sasaki D, Yamashita T, Fukuda H, Hayashi T, Tabata T, Osawa R, Hirata KI, Kondo A. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease. J Atheroscler Thromb 2019;26:705-19. [PMID: 30587666 DOI: 10.5551/jat.47415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
170 Zhong KX, Cho A, Deeg CM, Chan AM, Suttle CA. Revealing the composition of the eukaryotic microbiome of oyster spat by CRISPR-Cas Selective Amplicon Sequencing (CCSAS). Microbiome 2021;9:230. [PMID: 34823604 DOI: 10.1186/s40168-021-01180-0] [Reference Citation Analysis]
171 Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, Hoshi N, Hatano N, Ozawa G, Sasaki N, Mizoguchi T, Amin HZ, Hirota Y, Ogawa W, Yamada T, Hirata KI. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation. 2018;138:2486-2498. [PMID: 30571343 DOI: 10.1161/circulationaha.118.033714] [Cited by in Crossref: 93] [Cited by in F6Publishing: 59] [Article Influence: 31.0] [Reference Citation Analysis]
172 Li X, Liang S, Xia Z, Qu J, Liu H, Liu C, Yang H, Wang J, Madsen L, Hou Y, Li J, Jia H, Kristiansen K, Xiao L. Establishment of a Macaca fascicularis gut microbiome gene catalog and comparison with the human, pig, and mouse gut microbiomes. Gigascience 2018;7. [PMID: 30137359 DOI: 10.1093/gigascience/giy100] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
173 Doran S, Arif M, Lam S, Bayraktar A, Turkez H, Uhlen M, Boren J, Mardinoglu A. Multi-omics approaches for revealing the complexity of cardiovascular disease. Brief Bioinform 2021:bbab061. [PMID: 33725119 DOI: 10.1093/bib/bbab061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Castellanos N, Diez GG, Antúnez-Almagro C, Bailén M, Bressa C, González Soltero R, Pérez M, Larrosa M. A Critical Mutualism - Competition Interplay Underlies the Loss of Microbial Diversity in Sedentary Lifestyle. Front Microbiol 2019;10:3142. [PMID: 32038575 DOI: 10.3389/fmicb.2019.03142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
175 Şafak B, Altunan B, Topçu B, Eren Topkaya A. The gut microbiome in epilepsy. Microbial Pathogenesis 2020;139:103853. [DOI: 10.1016/j.micpath.2019.103853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
176 Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, Jin L, Chen X. The progress of gut microbiome research related to brain disorders. J Neuroinflammation 2020;17:25. [PMID: 31952509 DOI: 10.1186/s12974-020-1705-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 35.5] [Reference Citation Analysis]
177 Ramírez-Macías I, Orenes-Piñero E, Camelo-Castillo A, Rivera-Caravaca JM, López-García C, Marín F. Novel insights in the relationship of gut microbiota and coronary artery diseases. Crit Rev Food Sci Nutr 2021;:1-13. [PMID: 33399007 DOI: 10.1080/10408398.2020.1868397] [Reference Citation Analysis]
178 He C, Cheng D, Peng C, Li Y, Zhu Y, Lu N. High-Fat Diet Induces Dysbiosis of Gastric Microbiota Prior to Gut Microbiota in Association With Metabolic Disorders in Mice. Front Microbiol 2018;9:639. [PMID: 29686654 DOI: 10.3389/fmicb.2018.00639] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
179 Pieczynska MD, Yang Y, Petrykowski S, Horbanczuk OK, Atanasov AG, Horbanczuk JO. Gut Microbiota and Its Metabolites in Atherosclerosis Development. Molecules 2020;25:E594. [PMID: 32013236 DOI: 10.3390/molecules25030594] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
180 Dong S, Jiao J, Jia S, Li G, Zhang W, Yang K, Wang Z, Liu C, Li D, Wang X. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome. Front Cell Infect Microbiol 2021;11:634981. [PMID: 34041041 DOI: 10.3389/fcimb.2021.634981] [Reference Citation Analysis]
181 Schupack DA, Mars RAT, Voelker DH, Abeykoon JP, Kashyap PC. The promise of the gut microbiome as part of individualized treatment strategies. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453142 DOI: 10.1038/s41575-021-00499-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Wu H, Chiou J. Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke. Nutrients 2021;13:2878. [PMID: 34445037 DOI: 10.3390/nu13082878] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Zhu C, Sawrey-Kubicek L, Bardagjy AS, Houts H, Tang X, Sacchi R, Randolph JM, Steinberg FM, Zivkovic AM. Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women. Nutr Res 2020;78:36-41. [PMID: 32464420 DOI: 10.1016/j.nutres.2020.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
184 Thomas AM, Asnicar F, Kroemer G, Segata N. Genes Encoding Microbial Acyl Coenzyme A Binding Protein/Diazepam-Binding Inhibitor Orthologs Are Rare in the Human Gut Microbiome and Show No Links to Obesity. Appl Environ Microbiol 2021;87:e0047121. [PMID: 33837018 DOI: 10.1128/AEM.00471-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Townsend EM, Kelly L, Muscatt G, Box JD, Hargraves N, Lilley D, Jameson E. The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome. Front Cell Infect Microbiol 2021;11:643214. [PMID: 34150671 DOI: 10.3389/fcimb.2021.643214] [Reference Citation Analysis]
186 Zhang M, Liu D, Zhou H, Liu X, Li X, Cheng Y, Gao B, Chen J. Intestinal flora characteristics of advanced non-small cell lung cancer in China and their role in chemotherapy based on metagenomics: A prospective exploratory cohort study. Thorac Cancer 2021. [PMID: 34693651 DOI: 10.1111/1759-7714.14199] [Reference Citation Analysis]
187 Liang X, Zhang Z, Lv Y, Lu H, Liu T, Yi H, Zhao M, Zhang L, Gong P. Krill Oil Combined with Bifidobacterium animalis subsp. lactis F1-7 Alleviates the Atherosclerosis of ApoE-/- Mice. Foods 2021;10:2374. [PMID: 34681423 DOI: 10.3390/foods10102374] [Reference Citation Analysis]
188 Shahriar S, Ahsan T, Khan A, Akhteruzzaman S, Shehreen S, Sajib AA. Aspartame, acesulfame K and sucralose- influence on the metabolism of Escherichia coli. Metabol Open 2020;8:100072. [PMID: 33336183 DOI: 10.1016/j.metop.2020.100072] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 Shen L, Shen K, Bai J, Wang J, Singla RK, Shen B. Data-driven microbiota biomarker discovery for personalized drug therapy of cardiovascular disease. Pharmacol Res 2020;161:105225. [PMID: 33007417 DOI: 10.1016/j.phrs.2020.105225] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Li H, Wu G, Zhao L, Zhang M. Suppressed inflammation in obese children induced by a high-fiber diet is associated with the attenuation of gut microbial virulence factor genes. Virulence 2021;12:1754-70. [PMID: 34233588 DOI: 10.1080/21505594.2021.1948252] [Reference Citation Analysis]
191 Chung E, Elmassry MM, Cao JJ, Kaur G, Dufour JM, Hamood AN, Shen CL. Beneficial effect of dietary geranylgeraniol on glucose homeostasis and bone microstructure in obese mice is associated with suppression of proinflammation and modification of gut microbiome. Nutr Res 2021;93:27-37. [PMID: 34352722 DOI: 10.1016/j.nutres.2021.07.001] [Reference Citation Analysis]
192 Huang K, Liu C, Peng M, Su Q, Liu R, Guo Z, Chen S, Li Z, Chang G. Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E-Deficient Mice. J Am Heart Assoc 2021;10:e019820. [PMID: 33787322 DOI: 10.1161/JAHA.120.019820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Kim M, Huda MN, Bennett BJ. Sequence Meets Function-Microbiota And Cardiovascular Disease. Cardiovasc Res 2021:cvab030. [PMID: 33537709 DOI: 10.1093/cvr/cvab030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Gómez de Cedrón M, Wagner S, Reguero M, Menéndez-Rey A, de Molina AR. Miracle Berry as a Potential Supplement in the Control of Metabolic Risk Factors in Cancer. Antioxidants (Basel) 2020;9:E1282. [PMID: 33333960 DOI: 10.3390/antiox9121282] [Reference Citation Analysis]
195 Su J, Zhao Q, Zhao A, Jia W, Zhu W, Lu J, Ma X. Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study. Acta Diabetol 2021;58:1217-24. [PMID: 33871690 DOI: 10.1007/s00592-021-01717-7] [Reference Citation Analysis]
196 Shanmugam M, Quareshy M, Cameron AD, Bugg TDH, Chen Y. Light‐Activated Electron Transfer and Catalytic Mechanism of Carnitine Oxidation by Rieske‐Type Oxygenase from Human Microbiota. Angew Chem 2021;133:4579-84. [DOI: 10.1002/ange.202012381] [Reference Citation Analysis]
197 Sun S, Wang H, Tsilimigras MC, Howard AG, Sha W, Zhang J, Su C, Wang Z, Du S, Sioda M, Fouladi F, Fodor A, Gordon-Larsen P, Zhang B. Does geographical variation confound the relationship between host factors and the human gut microbiota: a population-based study in China. BMJ Open 2020;10:e038163. [PMID: 33444181 DOI: 10.1136/bmjopen-2020-038163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules 2020;10:E291. [PMID: 32069832 DOI: 10.3390/biom10020291] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 23.5] [Reference Citation Analysis]
199 Annunziata G, Ciampaglia R, Maisto M, D'Avino M, Caruso D, Tenore GC, Novellino E. Taurisolo®, a Grape Pomace Polyphenol Nutraceutical Reducing the Levels of Serum Biomarkers Associated With Atherosclerosis. Front Cardiovasc Med 2021;8:697272. [PMID: 34350218 DOI: 10.3389/fcvm.2021.697272] [Reference Citation Analysis]
200 Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front Immunol 2020;11:906. [PMID: 32582143 DOI: 10.3389/fimmu.2020.00906] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 32.5] [Reference Citation Analysis]
201 Kappel BA, Lehrke M. Mikrobiom, Diabetes und Herz: neue Zusammenhänge? Herz 2019;44:223-30. [DOI: 10.1007/s00059-019-4791-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Li Q, Gao B, Siqin B, He Q, Zhang R, Meng X, Zhang N, Zhang N, Li M. Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids. Front Pharmacol 2021;12:651926. [PMID: 34220497 DOI: 10.3389/fphar.2021.651926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Shen N, Caixàs A, Ahlers M, Patel K, Gao Z, Dutia R, Blaser MJ, Clemente JC, Laferrère B. Longitudinal changes of microbiome composition and microbial metabolomics after surgical weight loss in individuals with obesity. Surg Obes Relat Dis 2019;15:1367-73. [PMID: 31296445 DOI: 10.1016/j.soard.2019.05.038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
204 Liu X, Tong X, Zou Y, Lin X, Zhao H, Tian L, Jie Z, Wang Q, Zhang Z, Lu H, Xiao L, Qiu X, Zi J, Wang R, Xu X, Yang H, Wang J, Zong Y, Liu W, Hou Y, Zhu S, Jia H, Zhang T. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet 2022;54:52-61. [PMID: 34980918 DOI: 10.1038/s41588-021-00968-y] [Reference Citation Analysis]
205 Zheng YY, Wu TT, Liu ZQ, Li A, Guo QQ, Ma YY, Zhang ZL, Xun YL, Zhang JC, Wang WR, Kadir P, Wang DY, Ma YT, Zhang JY, Xie X. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease. J Agric Food Chem 2020;68:3548-57. [PMID: 32100534 DOI: 10.1021/acs.jafc.0c00225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
206 Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I. Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population. Atherosclerosis 2019;286:53-9. [PMID: 31100620 DOI: 10.1016/j.atherosclerosis.2019.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
207 Wang X, Xia J, Jiang C. Role of gut microbiota in the development of non-alcoholic fatty liver disease. Liver Research 2019;3:25-30. [DOI: 10.1016/j.livres.2019.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Silveira-Nunes G, Durso DF, Jr LRAO, Cunha EHM, Maioli TU, Vieira AT, Speziali E, Corrêa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Franceschi C, Rampelli S, Turroni S, Brigidi P, Faria AMC. Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population. Front Pharmacol 2020;11:258. [PMID: 32226382 DOI: 10.3389/fphar.2020.00258] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
209 Park Y, Lee J, Moon H, Choi YS, Rho M. Discovering microbe-disease associations from the literature using a hierarchical long short-term memory network and an ensemble parser model. Sci Rep 2021;11:4490. [PMID: 33627732 DOI: 10.1038/s41598-021-83966-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
210 Aron-wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Clément K. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol 2020;17:279-97. [DOI: 10.1038/s41575-020-0269-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 51.5] [Reference Citation Analysis]
211 Jin M, Qian Z, Yin J, Xu W, Zhou X. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med 2019;23:2343-50. [PMID: 30712327 DOI: 10.1111/jcmm.14195] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
212 Liu X, Tang S, Zhong H, Tong X, Jie Z, Ding Q, Wang D, Guo R, Xiao L, Xu X, Yang H, Wang J, Zong Y, Liu X, Zhang Y, Brix S, Kristiansen K, Hou Y, Jia H, Zhang T. M-GWAS for the Gut Microbiome in Chinese Adults Illuminates on Complex Diseases. SSRN Journal. [DOI: 10.2139/ssrn.3383800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
214 Warmbrunn MV, Herrema H, Aron-Wisnewsky J, Soeters MR, Van Raalte DH, Nieuwdorp M. Gut microbiota: a promising target against cardiometabolic diseases. Expert Rev Endocrinol Metab 2020;15:13-27. [PMID: 32066294 DOI: 10.1080/17446651.2020.1720511] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
215 Xu X, Zhang W, Guo M, Xiao C, Fu Z, Yu S, Jiang L, Wang S, Ling Y, Liu F, Tan Y, Chen S. Integrated analysis of gut microbiome and host immune responses in COVID-19. Front Med 2022. [PMID: 35258762 DOI: 10.1007/s11684-022-0921-6] [Reference Citation Analysis]
216 Suganya K, Son T, Kim KW, Koo BS. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases. Microb Pathog 2021;152:104583. [PMID: 33164814 DOI: 10.1016/j.micpath.2020.104583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
217 Bartolomaeus TUP, Birkner T, Bartolomaeus H, Löber U, Avery EG, Mähler A, Weber D, Kochlik B, Balogh A, Wilck N, Boschmann M, Müller DN, Markó L, Forslund SK. Quantifying technical confounders in microbiome studies. Cardiovasc Res 2021;117:863-75. [PMID: 32374853 DOI: 10.1093/cvr/cvaa128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
218 Zhang WQ, Wang YJ, Zhang A, Ding YJ, Zhang XN, Jia QJ, Zhu YP, Li YY, Lv SC, Zhang JP. TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies. J Cardiovasc Transl Res 2021. [PMID: 33709384 DOI: 10.1007/s12265-021-10115-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, Qin Y, Liu X, Li S, Cai J, Zhong J, Yang X. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience 2019;8:giz058. [PMID: 31149718 DOI: 10.1093/gigascience/giz058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
220 Sudheer S, Gangwar P, Usmani Z, Sharma M, Sharma VK, Sana SS, Almeida F, Dubey NK, Singh DP, Dilbaghi N, Khayat Kashani HR, Gupta VK, Singh BN, Khayatkashani M, Nabavi SM. Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases. Biochimie 2021:S0300-9084(21)00247-9. [PMID: 34688789 DOI: 10.1016/j.biochi.2021.10.010] [Reference Citation Analysis]
221 Li P, Cai X, Xiao N, Ma X, Zeng L, Zhang LH, Xie L, Du B. Sacha inchi (Plukenetia volubilis L.) shell extract alleviates hypertension in association with the regulation of gut microbiota. Food Funct 2020;11:8051-67. [PMID: 32852030 DOI: 10.1039/d0fo01770a] [Reference Citation Analysis]
222 Ayala-García JC, Lagunas-Martínez A, Díaz-Benítez CE, Orbe-Orihuela YC, Castañeda-Márquez AC, Ortiz-Panozo E, Bermúdez-Morales VH, Bahena-Román M, Cruz M, Burguete-García AI. High Relative Abundance of Staphylococcus aureus and Serum Cytokines Are Associated with Cardiometabolic Abnormalities in Children. Metab Syndr Relat Disord 2022. [PMID: 35325575 DOI: 10.1089/met.2021.0084] [Reference Citation Analysis]
223 Geng H, Shu S, Dong J, Li H, Xu C, Han Y, Hu J, Han Y, Yang R, Cheng N. Association study of gut flora in Wilson's disease through high-throughput sequencing. Medicine (Baltimore) 2018;97:e11743. [PMID: 30075590 DOI: 10.1097/MD.0000000000011743] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
224 Wirbel J, Zych K, Essex M, Karcher N, Kartal E, Salazar G, Bork P, Sunagawa S, Zeller G. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol 2021;22:93. [PMID: 33785070 DOI: 10.1186/s13059-021-02306-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
225 Yang X, Feng H, Zhan X, Zhang C, Cui R, Zhong L, Ying S, Chen Z. Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis. Aging (Albany NY) 2019;11:2071-81. [PMID: 30981206 DOI: 10.18632/aging.101901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
226 Mateo-Gallego R, Moreno-Indias I, Bea AM, Sánchez-Alcoholado L, Fumanal AJ, Quesada-Molina M, Prieto-Martín A, Gutiérrez-Repiso C, Civeira F, Tinahones FJ. An alcohol-free beer enriched with isomaltulose and a resistant dextrin modulates gut microbiome in subjects with type 2 diabetes mellitus and overweight or obesity: a pilot study. Food Funct 2021;12:3635-46. [PMID: 33900319 DOI: 10.1039/d0fo03160g] [Reference Citation Analysis]
227 Zhang X, Zhong H, Li Y, Shi Z, Ren H, Zhang Z, Zhou X, Tang S, Han X, Lin Y, Yang F, Wang D, Fang C, Fu Z, Wang L, Zhu S, Hou Y, Xu X, Yang H, Wang J, Kristiansen K, Li J, Ji L. Sex- and age-related trajectories of the adult human gut microbiota shared across populations of different ethnicities. Nat Aging 2021;1:87-100. [DOI: 10.1038/s43587-020-00014-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 19.0] [Reference Citation Analysis]
228 Cason CA, Kuntz TM, Chen EB, Wun K, Nooromid MJ, Xiong L, Gottel NR, Harris KG, Morton TC, Avram MJ, Chang EB, Gilbert JA, Ho KJ. Microbiota composition modulates inflammation and neointimal hyperplasia after arterial angioplasty. J Vasc Surg 2020;71:1378-1389.e3. [PMID: 32035769 DOI: 10.1016/j.jvs.2019.06.208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Szabo H, Hernyes A, Piroska M, Ligeti B, Fussy P, Zoldi L, Galyasz S, Makra N, Szabo D, Tarnoki AD, Tarnoki DL. Association between Gut Microbial Diversity and Carotid Intima-Media Thickness. Medicina (Kaunas) 2021;57:195. [PMID: 33668894 DOI: 10.3390/medicina57030195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Kehrmann J, Menzel J, Saeedghalati M, Obeid R, Schulze C, Holzendorf V, Farahpour F, Reinsch N, Klein-Hitpass L, Streeck H, Hoffmann D, Buer J, Esser S; HIV-HEART Study Group. Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease. J Infect Dis 2019;219:497-508. [PMID: 30202890 DOI: 10.1093/infdis/jiy524] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
231 Ding QY, Tian JX, Li M, Lian FM, Zhao LH, Wei XX, Han L, Zheng YJ, Gao ZZ, Yang HY, Fang XY, Tong XL. Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota. Front Cell Infect Microbiol 2020;10:530160. [PMID: 33194785 DOI: 10.3389/fcimb.2020.530160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Liu F, Fan C, Zhang L, Li Y, Hou H, Ma Y, Fan J, Tan Y, Wu T, Jia S, Zhang Y. Alterations of Gut Microbiome in Tibetan Patients With Coronary Heart Disease. Front Cell Infect Microbiol 2020;10:373. [PMID: 32793515 DOI: 10.3389/fcimb.2020.00373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
233 Usova EI, Alieva AS, Yakovlev AN, Alieva MS, Prokhorikhin AA, Konradi AO, Shlyakhto EV, Magni P, Catapano AL, Baragetti A. Integrative Analysis of Multi-Omics and Genetic Approaches-A New Level in Atherosclerotic Cardiovascular Risk Prediction. Biomolecules 2021;11:1597. [PMID: 34827594 DOI: 10.3390/biom11111597] [Reference Citation Analysis]
234 Tisza MJ, Buck CB. A catalog of tens of thousands of viruses from human metagenomes reveals hidden associations with chronic diseases. Proc Natl Acad Sci U S A 2021;118:e2023202118. [PMID: 34083435 DOI: 10.1073/pnas.2023202118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
235 Zhu C, Wang X, Li J, Jiang R, Chen H, Chen T, Yang Y. Determine independent gut microbiota-diseases association by eliminating the effects of human lifestyle factors. BMC Microbiol 2022;22:4. [PMID: 34979898 DOI: 10.1186/s12866-021-02414-9] [Reference Citation Analysis]
236 Leentjens J, Bekkering S, Joosten LAB, Netea MG, Burgner DP, Riksen NP. Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis. Circ Res 2018;122:664-9. [PMID: 29367213 DOI: 10.1161/CIRCRESAHA.117.312465] [Cited by in Crossref: 64] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
237 Liu Y, Dai M. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis. Mediators Inflamm 2020;2020:4634172. [PMID: 32148438 DOI: 10.1155/2020/4634172] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
238 Chen B, Lin W, Li Y, Bi C, Du L, Liu Y, Zhou L, Liu T, Xu S, Shi C, Zhu H, Wang Y, Sun J, Liu Y, Zhang W, Lu H, Wang Y, Feng Q, Chen F, Wang C, Tonetti MS, Zhu Y, Zhang H, Duan S. Roles of oral microbiota and oral-gut microbial transmission in hypertension. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.03.007] [Reference Citation Analysis]
239 Jie Z, Chen C, Hao L, Li F, Song L, Zhang X, Zhu J, Tian L, Tong X, Cai K, Zhang Z, Ju Y, Yu X, Li Y, Zhou H, Lu H, Qiu X, Li Q, Liao Y, Zhou D, Lian H, Zuo Y, Chen X, Rao W, Ren Y, Wang Y, Zi J, Wang R, Liu N, Wu J, Zhang W, Liu X, Zong Y, Liu W, Xiao L, Hou Y, Xu X, Yang H, Wang J, Kristiansen K, Jia H. Life History Recorded in the Vagino-cervical Microbiome Along with Multi-omics. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00099-1. [PMID: 34118463 DOI: 10.1016/j.gpb.2021.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
240 Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, Beghini F, Manara S, Karcher N, Pozzi C, Gandini S, Serrano D, Tarallo S, Francavilla A, Gallo G, Trompetto M, Ferrero G, Mizutani S, Shiroma H, Shiba S, Shibata T, Yachida S, Yamada T, Wirbel J, Schrotz-King P, Ulrich CM, Brenner H, Arumugam M, Bork P, Zeller G, Cordero F, Dias-Neto E, Setubal JC, Tett A, Pardini B, Rescigno M, Waldron L, Naccarati A, Segata N. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med 2019;25:667-78. [PMID: 30936548 DOI: 10.1038/s41591-019-0405-7] [Cited by in Crossref: 208] [Cited by in F6Publishing: 189] [Article Influence: 69.3] [Reference Citation Analysis]
241 Francescangeli F, De Angelis ML, Zeuner A. Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer. Nutrients 2019;11:E2936. [PMID: 31816977 DOI: 10.3390/nu11122936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
242 Heianza Y, Ma W, DiDonato JA, Sun Q, Rimm EB, Hu FB, Rexrode KM, Manson JE, Qi L. Ten-year changes in plasma L-carnitine levels and risk of coronary heart disease. Eur J Nutr 2021. [PMID: 34799774 DOI: 10.1007/s00394-021-02713-x] [Reference Citation Analysis]
243 Jang J, Kim Y, Hwang J, Choi Y, Tanaka M, Kang E, Choi J. Biological Responses of Onion-Shaped Carbon Nanoparticles. Nanomaterials (Basel) 2019;9:E1016. [PMID: 31311181 DOI: 10.3390/nano9071016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
244 Liu X, Tong X, Zhu J, Tian L, Jie Z, Zou Y, Lin X, Liang H, Li W, Ju Y, Qin Y, Zou L, Lu H, Zhu S, Jin X, Xu X, Yang H, Wang J, Zong Y, Liu W, Hou Y, Jia H, Zhang T. Metagenome-genome-wide association studies reveal human genetic impact on the oral microbiome. Cell Discov 2021;7:117. [PMID: 34873157 DOI: 10.1038/s41421-021-00356-0] [Reference Citation Analysis]
245 Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol 2021;12:519836. [PMID: 34054740 DOI: 10.3389/fmicb.2021.519836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
246 Mobegi FM, Leong LE, Thompson F, Taylor SM, Harriss LR, Choo JM, Taylor SL, Wesselingh SL, McDermott R, Ivey KL, Rogers GB. Intestinal microbiology shapes population health impacts of diet and lifestyle risk exposures in Torres Strait Islander communities. Elife 2020;9:e58407. [PMID: 33074097 DOI: 10.7554/eLife.58407] [Reference Citation Analysis]
247 Chen L, Collij V, Jaeger M, van den Munckhof ICL, Vich Vila A, Kurilshikov A, Gacesa R, Sinha T, Oosting M, Joosten LAB, Rutten JHW, Riksen NP, Xavier RJ, Kuipers F, Wijmenga C, Zhernakova A, Netea MG, Weersma RK, Fu J. Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity. Nat Commun 2020;11:4018. [PMID: 32782301 DOI: 10.1038/s41467-020-17840-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
248 Zhang L, Shi Y, Do KA, Peterson CB, Jenq RR. ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries. BMC Bioinformatics 2021;22:126. [PMID: 33731016 DOI: 10.1186/s12859-021-04061-3] [Reference Citation Analysis]
249 Young RB, Marcelino VR, Chonwerawong M, Gulliver EL, Forster SC. Key Technologies for Progressing Discovery of Microbiome-Based Medicines. Front Microbiol 2021;12:685935. [PMID: 34239510 DOI: 10.3389/fmicb.2021.685935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
250 Liu H, Tian R, Wang H, Feng S, Li H, Xiao Y, Luan X, Zhang Z, Shi N, Niu H, Zhang S. Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation. J Transl Med 2020;18:382. [PMID: 33036625 DOI: 10.1186/s12967-020-02539-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
251 Lai S, Molfino A, Testorio M, Perrotta AM, Currado A, Pintus G, Pietrucci D, Unida V, La Rocca D, Biocca S, Desideri A. Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease. Nutrients 2019;11:E3006. [PMID: 31818021 DOI: 10.3390/nu11123006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
252 Zhu J, Tian L, Chen P, Han M, Song L, Tong X, Sun X, Yang F, Lin Z, Liu X, Liu C, Wang X, Lin Y, Cai K, Hou Y, Xu X, Yang H, Wang J, Kristiansen K, Xiao L, Zhang T, Jia H, Jie Z. Over 50,000 Metagenomically Assembled Draft Genomes for the Human Oral Microbiome Reveal New Taxa. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00176-5. [PMID: 34492339 DOI: 10.1016/j.gpb.2021.05.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Ma T, Xiao D, Xing X. MetaBMF: a scalable binning algorithm for large-scale reference-free metagenomic studies. Bioinformatics 2020;36:356-63. [PMID: 31347687 DOI: 10.1093/bioinformatics/btz577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
254 Alferink LJM, Radjabzadeh D, Erler NS, Vojinovic D, Medina-Gomez C, Uitterlinden AG, de Knegt RJ, Amin N, Ikram MA, Janssen HLA, Kiefte-de Jong JC, Metselaar HJ, van Duijn CM, Kraaij R, Darwish Murad S. Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population-Based Study of 1,355 Adults.Hepatology. 2021;73:968-982. [PMID: 32530501 DOI: 10.1002/hep.31417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
255 Ajayi A, Jolaiya T, Smith S. Evolving Technologies in Gastrointestinal Microbiome Era and Their Potential Clinical Applications. J Clin Med 2020;9:E2565. [PMID: 32784731 DOI: 10.3390/jcm9082565] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
256 Li Y, Shi G, Han Y, Shang H, Li H, Liang W, Zhao W, Bai L, Qin C. Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model. Stem Cell Res Ther 2021;12:407. [PMID: 34266502 DOI: 10.1186/s13287-021-02490-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
257 [DOI: 10.1101/2020.02.23.20027029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Piscitelli F, Silvestri C. Role of the Endocannabinoidome in Human and Mouse Atherosclerosis. Curr Pharm Des 2019;25:3147-64. [PMID: 31448709 DOI: 10.2174/1381612825666190826162735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
259 Heianza Y, Zheng Y, Ma W, Rimm EB, Albert CM, Hu FB, Rexrode KM, Manson JE, Qi L. Duration and life-stage of antibiotic use and risk of cardiovascular events in women. Eur Heart J 2019;40:3838-45. [PMID: 31216010 DOI: 10.1093/eurheartj/ehz231] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
260 Yue C, Li M, Li J, Han X, Zhu H, Yu G, Cheng J. Medium-, long- and medium-chain-type structured lipids ameliorate high-fat diet-induced atherosclerosis by regulating inflammation, adipogenesis, and gut microbiota in ApoE-/- mice. Food Funct 2020;11:5142-55. [PMID: 32432606 DOI: 10.1039/d0fo01006e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
261 Teichman EM, O'Riordan KJ, Gahan CGM, Dinan TG, Cryan JF. When Rhythms Meet the Blues: Circadian Interactions with the Microbiota-Gut-Brain Axis. Cell Metab 2020;31:448-71. [PMID: 32130879 DOI: 10.1016/j.cmet.2020.02.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 29.0] [Reference Citation Analysis]
262 Jie Z, Liang S, Ding Q, Li F, Sun X, Lin Y, Chen P, Cai K, Wang X, Zhang T, Zhou H, Lu H, Xiao L, Yang H, Wang J, Hou Y, Kristiansen K, Jia H, Xu X. Dairy consumption and physical fitness tests associated with fecal microbiome in a Chinese cohort. Medicine in Microecology 2021;9:100038. [DOI: 10.1016/j.medmic.2021.100038] [Reference Citation Analysis]
263 Zuo K, Li J, Wang P, Liu Y, Liu Z, Yin X, Liu X, Yang X. Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes. mSystems 2019;4:e00422-19. [PMID: 31822598 DOI: 10.1128/mSystems.00422-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
264 Wu Y, Zhu B, Chen Z, Duan J, Luo A, Yang L, Yang C. New Insights Into the Comorbidity of Coronary Heart Disease and Depression. Curr Probl Cardiol 2021;46:100413. [PMID: 31005351 DOI: 10.1016/j.cpcardiol.2019.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
265 Ortega-Vega EL, Guzmán-Castañeda SJ, Campo O, Velásquez-Mejía EP, de la Cuesta-Zuluaga J, Bedoya G, Escobar JS. Variants in genes of innate immunity, appetite control and energy metabolism are associated with host cardiometabolic health and gut microbiota composition. Gut Microbes 2020;11:556-68. [PMID: 31154934 DOI: 10.1080/19490976.2019.1619440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
266 Xu J, Zhao M, Wang A, Xue J, Cheng S, Cheng A, Gao J, Zhang Q, Zhan R, Meng X, Xu M, Li H, Zheng L, Wang Y. Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke. J Am Heart Assoc 2021;10:e020979. [PMID: 34816729 DOI: 10.1161/JAHA.121.020979] [Reference Citation Analysis]
267 Baragetti A, Severgnini M, Olmastroni E, Dioguardi CC, Mattavelli E, Angius A, Rotta L, Cibella J, Caredda G, Consolandi C, Grigore L, Pellegatta F, Giavarini F, Caruso D, Norata GD, Catapano AL, Peano C. Gut Microbiota Functional Dysbiosis Relates to Individual Diet in Subclinical Carotid Atherosclerosis. Nutrients 2021;13:304. [PMID: 33494335 DOI: 10.3390/nu13020304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
268 McKenzie ND, Hong H, Ahmad S, Holloway RW. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research. Crit Rev Oncol Hematol 2021;157:103165. [PMID: 33227575 DOI: 10.1016/j.critrevonc.2020.103165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
269 Odenwald MA, Chapman CG. Gut dysbiosis and its epigenomic impact on disease. Nutritional Epigenomics. Elsevier; 2019. pp. 409-22. [DOI: 10.1016/b978-0-12-816843-1.00025-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
270 Guzzardi M, Ait Ali L, D'aurizio R, Rizzo F, Saggese P, Sanguinetti E, Weisz A, Pellegrini M, Iozzo P. Fetal cardiac growth is associated with in utero gut colonization. Nutrition, Metabolism and Cardiovascular Diseases 2019;29:170-6. [DOI: 10.1016/j.numecd.2018.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
271 Le ST, Toussi A, Maverakis N, Marusina AI, Barton VR, Merleev AA, Luxardi G, Raychaudhuri SP, Maverakis E. The cutaneous and intestinal microbiome in psoriatic disease. Clin Immunol 2020;218:108537. [PMID: 32679247 DOI: 10.1016/j.clim.2020.108537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
272 Huo JY, Jiang WY, Yin T, Xu H, Lyu YT, Chen YY, Chen M, Geng J, Jiang ZX, Shan QJ. Intestinal Barrier Dysfunction Exacerbates Neuroinflammation via the TLR4 Pathway in Mice With Heart Failure. Front Physiol 2021;12:712338. [PMID: 34421655 DOI: 10.3389/fphys.2021.712338] [Reference Citation Analysis]
273 Zhang Q, Hu J, Feng JW, Hu XT, Wang T, Gong WX, Huang K, Guo YX, Zou Z, Lin X, Zhou R, Yuan YQ, Zhang AD, Wei H, Cao G, Liu C, Chen LL, Jin ML. Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection. Genome Biol 2020;21:99. [PMID: 32345342 DOI: 10.1186/s13059-020-02007-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
274 de Alvarenga JFR, Genaro B, Costa BL, Purgatto E, Manach C, Fiamoncini J. Monoterpenes: current knowledge on food source, metabolism, and health effects. Crit Rev Food Sci Nutr 2021;:1-38. [PMID: 34387521 DOI: 10.1080/10408398.2021.1963945] [Reference Citation Analysis]
275 Zuo K, Liu X, Wang P, Jiao J, Han C, Liu Z, Yin X, Li J, Yang X. Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients. BMC Genomics 2020;21:526. [PMID: 32731896 DOI: 10.1186/s12864-020-06944-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
276 Hu C, Wang P, Yang Y, Li J, Jiao X, Yu H, Wei Y, Li J, Qin Y. Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota. Front Cell Infect Microbiol 2021;11:560201. [PMID: 34277461 DOI: 10.3389/fcimb.2021.560201] [Reference Citation Analysis]
277 Ling Z, Liu X, Cheng Y, Yan X, Wu S. Gut microbiota and aging. Crit Rev Food Sci Nutr 2020;:1-56. [PMID: 33377391 DOI: 10.1080/10408398.2020.1867054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Wang T, Guo XK, Xu H. Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota. Front Microbiol 2021;12:728823. [PMID: 34721326 DOI: 10.3389/fmicb.2021.728823] [Reference Citation Analysis]
279 Guo M, Chen J, Li Q, Fu Y, Fan G, Ma J, Peng L, Zeng L, Chen J, Wang Y, Lee SM. Dynamics of Gut Microbiome in Giant Panda Cubs Reveal Transitional Microbes and Pathways in Early Life. Front Microbiol 2018;9:3138. [PMID: 30619206 DOI: 10.3389/fmicb.2018.03138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
280 Gerdes V, Gueimonde M, Pajunen L, Nieuwdorp M, Laitinen K. How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way? Atherosclerosis 2020;311:124-42. [PMID: 32981713 DOI: 10.1016/j.atherosclerosis.2020.08.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
281 Brocker CN, Velenosi T, Flaten HK, McWilliams G, McDaniel K, Shelton SK, Saben J, Krausz KW, Gonzalez FJ, Monte AA. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genomics 2020;14:10. [PMID: 32160915 DOI: 10.1186/s40246-020-00260-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
282 Cai YY, Huang FQ, Lao X, Lu Y, Gao X, Alolga RN, Yin K, Zhou X, Wang Y, Liu B, Shang J, Qi LW, Li J. Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis. NPJ Biofilms Microbiomes 2022;8:11. [PMID: 35273169 DOI: 10.1038/s41522-022-00273-4] [Reference Citation Analysis]
283 Bach Knudsen KE, Lærke HN, Hedemann MS, Nielsen TS, Ingerslev AK, Gundelund Nielsen DS, Theil PK, Purup S, Hald S, Schioldan AG, Marco ML, Gregersen S, Hermansen K. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation. Nutrients 2018;10:E1499. [PMID: 30322146 DOI: 10.3390/nu10101499] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 31.8] [Reference Citation Analysis]
284 Ding RX, Goh WR, Wu RN, Yue XQ, Luo X, Khine WWT, Wu JR, Lee YK. Revisit gut microbiota and its impact on human health and disease. J Food Drug Anal. 2019;27:623-631. [PMID: 31324279 DOI: 10.1016/j.jfda.2018.12.012] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 20.0] [Reference Citation Analysis]
285 Miryala SK, Anbarasu A, Ramaiah S. Gene interaction network to unravel the role of gut bacterial species in cardiovascular diseases: E. coli O157:H7 host-bacterial interaction study. Comput Biol Med 2021;133:104417. [PMID: 33901711 DOI: 10.1016/j.compbiomed.2021.104417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
286 Yan Z, Wu H, Zhou H, Chen S, He Y, Zhang W, Chen T, Yao H, Su W. Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats. Sci Rep 2020;10:10829. [PMID: 32616735 DOI: 10.1038/s41598-020-67362-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
287 Ma Y, Zhu L, Ma Z, Gao Z, Wei Y, Shen Y, Li L, Liu X, Ren M. Distinguishing feature of gut microbiota in Tibetan highland coronary artery disease patients and its link with diet. Sci Rep 2021;11:18486. [PMID: 34531508 DOI: 10.1038/s41598-021-98075-9] [Reference Citation Analysis]
288 Haque M, Islam S, Sheikh MA, Dhingra S, Uwambaye P, Labricciosa FM, Iskandar K, Charan J, Abukabda AB, Jahan D. Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases. Expert Rev Anti Infect Ther 2021;19:571-86. [PMID: 33131352 DOI: 10.1080/14787210.2021.1843427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
289 Herzog EL, Wäfler M, Keller I, Wolf S, Zinkernagel MS, Zysset-Burri DC. The importance of age in compositional and functional profiling of the human intestinal microbiome. PLoS One 2021;16:e0258505. [PMID: 34662347 DOI: 10.1371/journal.pone.0258505] [Reference Citation Analysis]
290 Grajeda-Iglesias C, Rom O, Aviram M. Branched-chain amino acids and atherosclerosis: friends or foes? Curr Opin Lipidol 2018;29:166-9. [PMID: 29517610 DOI: 10.1097/MOL.0000000000000494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
291 Hu X, Xing M, An S, Wan Y, Liu Q. The gut microbiota and heart disease prevention. Eur J Prev Cardiol 2019;26:109. [PMID: 29707964 DOI: 10.1177/2047487318775171] [Reference Citation Analysis]
292 Chen Z, Hui PC, Hui M, Yeoh YK, Wong PY, Chan MCW, Wong MCS, Ng SC, Chan FKL, Chan PKS. Impact of Preservation Method and 16S rRNA Hypervariable Region on Gut Microbiota Profiling. mSystems 2019;4:e00271-18. [PMID: 30834331 DOI: 10.1128/mSystems.00271-18] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 15.7] [Reference Citation Analysis]
293 Klimenko NS, Tyakht AV, Popenko AS, Vasiliev AS, Altukhov IA, Ischenko DS, Shashkova TI, Efimova DA, Nikogosov DA, Osipenko DA, Musienko SV, Selezneva KS, Baranova A, Kurilshikov AM, Toshchakov SM, Korzhenkov AA, Samarov NI, Shevchenko MA, Tepliuk AV, Alexeev DG. Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project. Nutrients 2018;10:E576. [PMID: 29738477 DOI: 10.3390/nu10050576] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 12.5] [Reference Citation Analysis]
294 Wun K, Theriault BR, Pierre JF, Chen EB, Leone VA, Harris KG, Xiong L, Jiang Q, Spedale M, Eskandari OM, Chang EB, Ho KJ. Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury. PLoS One 2018;13:e0208426. [PMID: 30521585 DOI: 10.1371/journal.pone.0208426] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
295 Chen W, Zhang S, Wu J, Ye T, Wang S, Wang P, Xing D. Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin Chim Acta 2020;507:236-41. [PMID: 32376324 DOI: 10.1016/j.cca.2020.04.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
296 Koethe JR, Lagathu C, Lake JE, Domingo P, Calmy A, Falutz J, Brown TT, Capeau J. HIV and antiretroviral therapy-related fat alterations. Nat Rev Dis Primers 2020;6:48. [PMID: 32555389 DOI: 10.1038/s41572-020-0181-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
297 Tran Q, Phan V. Assembling Reads Improves Taxonomic Classification of Species. Genes (Basel) 2020;11:E946. [PMID: 32824429 DOI: 10.3390/genes11080946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
298 Xue J, Allaband C, Zhou D, Poulsen O, Martino C, Jiang L, Tripathi A, Elijah E, Dorrestein PC, Knight R, Zarrinpar A, Haddad GG. Influence of Intermittent Hypoxia/Hypercapnia on Atherosclerosis, Gut Microbiome, and Metabolome. Front Physiol 2021;12:663950. [PMID: 33897472 DOI: 10.3389/fphys.2021.663950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
299 Kappel BA, De Angelis L, Heiser M, Ballanti M, Stoehr R, Goettsch C, Mavilio M, Artati A, Paoluzi OA, Adamski J, Mingrone G, Staels B, Burcelin R, Monteleone G, Menghini R, Marx N, Federici M. Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment. Mol Metab 2020;36:100976. [PMID: 32251665 DOI: 10.1016/j.molmet.2020.100976] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
300 Craven H, McGuinness D, Buchanan S, Galbraith N, McGuinness DH, Jones B, Combet E, Mafra D, Bergman P, Ellaway A, Stenvinkel P, Ijaz UZ, Shiels PG. Socioeconomic position links circulatory microbiota differences with biological age. Sci Rep 2021;11:12629. [PMID: 34135381 DOI: 10.1038/s41598-021-92042-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Ramezani A, Nolin TD, Barrows IR, Serrano MG, Buck GA, Regunathan-Shenk R, West RE 3rd, Latham PS, Amdur R, Raj DS. Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e-/- Mice. Sci Rep 2018;8:14752. [PMID: 30283097 DOI: 10.1038/s41598-018-33018-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
302 Wang Z, Usyk M, Sollecito CC, Qiu Y, Williams-Nguyen J, Hua S, Gradissimo A, Wang T, Xue X, Kurland IJ, Ley K, Landay AL, Anastos K, Knight R, Kaplan RC, Burk RD, Qi Q. Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus. Clin Infect Dis 2020;71:2345-53. [PMID: 31748797 DOI: 10.1093/cid/ciz1117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
303 Barrington WT, Lusis AJ. Atherosclerosis: Association between the gut microbiome and atherosclerosis. Nat Rev Cardiol 2017;14:699-700. [PMID: 29099096 DOI: 10.1038/nrcardio.2017.169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
304 Feng D, Christensen JT, Yetman AT, Lindsey ML, Singh AB, Salomon JD. The microbiome’s relationship with congenital heart disease: more than a gut feeling. J Congenit Heart Dis 2021;5. [DOI: 10.1186/s40949-021-00060-4] [Reference Citation Analysis]
305 Huang Y, Hang X, Jiang X, Zeng L, Jia J, Xie Y, Li F, Bi H. In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori. Antimicrob Agents Chemother. 2019;63. [PMID: 30936098 DOI: 10.1128/aac.00004-19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
306 Tang J, Qin M, Tang L, Shan D, Zhang C, Zhang Y, Wei H, Qiu L, Yu J. Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis. Food Funct 2021;12:9932-46. [PMID: 34492674 DOI: 10.1039/d1fo02021h] [Reference Citation Analysis]
307 Cretoiu D, Ionescu RF, Enache RM, Cretoiu SM, Voinea SC. Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link? Microorganisms 2021;9:1913. [PMID: 34576810 DOI: 10.3390/microorganisms9091913] [Reference Citation Analysis]
308 Kawabata S, Takagaki M, Nakamura H, Oki H, Motooka D, Nakamura S, Nishida T, Terada E, Izutsu N, Takenaka T, Matsui Y, Yamada S, Asai K, Tateishi A, Umehara T, Yano Y, Bamba Y, Matsumoto K, Kishikawa T, Okada Y, Iida T, Kishima H. Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms. Stroke 2021;:STROKEAHA121034792. [PMID: 34727738 DOI: 10.1161/STROKEAHA.121.034792] [Reference Citation Analysis]
309 Wang Z, Wang Q, Zhao J, Gong L, Zhang Y, Wang X, Yuan Z. Altered diversity and composition of the gut microbiome in patients with cervical cancer. AMB Express 2019;9:40. [PMID: 30904962 DOI: 10.1186/s13568-019-0763-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
310 Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS 2020;128:353-66. [PMID: 32108960 DOI: 10.1111/apm.13038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
311 Lewis CV, Taylor WR. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol 2020;319:H1227-33. [PMID: 32986965 DOI: 10.1152/ajpheart.00612.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
312 Zhao L, Yang L, Guo Y, Xiao J, Zhang J, Xu S. New Insights into Stroke Prevention and Treatment: Gut Microbiome. Cell Mol Neurobiol 2021. [PMID: 33635417 DOI: 10.1007/s10571-021-01047-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Stamm P, Kalinovic S, Oelze M, Steven S, Czarnowski A, Kvandova M, Bayer F, Reinhardt C, Münzel T, Daiber A. Mechanistic Insights into Inorganic Nitrite-Mediated Vasodilation of Isolated Aortic Rings under Oxidative/Hypertensive Conditions and S-Nitros(yl)ation of Proteins in Germ-Free Mice. Biomedicines 2022;10:730. [PMID: 35327532 DOI: 10.3390/biomedicines10030730] [Reference Citation Analysis]
314 Dekker Nitert M. Knights in Shining Armor. Circ Res 2019;124:12-4. [PMID: 30605411 DOI: 10.1161/CIRCRESAHA.118.314246] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
315 Colijn S, Muthukumar V, Xie J, Gao S, Griffin CT. Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis. Dis Model Mech 2020;13:dmm041962. [PMID: 31953345 DOI: 10.1242/dmm.041962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
316 Shen X, Li L, Sun Z, Zang G, Zhang L, Shao C, Wang Z. Gut Microbiota and Atherosclerosis-Focusing on the Plaque Stability. Front Cardiovasc Med 2021;8:668532. [PMID: 34414217 DOI: 10.3389/fcvm.2021.668532] [Reference Citation Analysis]
317 Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, Abadia-Molina F. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients 2020;12:E605. [PMID: 32110880 DOI: 10.3390/nu12030605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
318 Kasahara K, Rey FE. The emerging role of gut microbial metabolism on cardiovascular disease. Current Opinion in Microbiology 2019;50:64-70. [DOI: 10.1016/j.mib.2019.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
319 dos Santos Cruz BC, da Silva Duarte V, Giacomini A, Corich V, de Paula SO, da Silva Fialho L, Guimarães VM, de Luces Fortes Ferreira CL, Gouveia Peluzio MDC. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model. Appl Microbiol Biotechnol 2020;104:8837-57. [DOI: 10.1007/s00253-020-10863-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
320 Jobira B, Frank DN, Pyle L, Silveira LJ, Kelsey MM, Garcia-Reyes Y, Robertson CE, Ir D, Nadeau KJ, Cree-Green M. Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota. J Clin Endocrinol Metab. 2020;105. [PMID: 31970418 DOI: 10.1210/clinem/dgz263] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 26.0] [Reference Citation Analysis]
321 Liu B, Zhang Y, Wang R, An Y, Gao W, Bai L, Li Y, Zhao S, Fan J, Liu E. Western diet feeding influences gut microbiota profiles in apoE knockout mice. Lipids Health Dis. 2018;17:159. [PMID: 30021609 DOI: 10.1186/s12944-018-0811-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
322 Liu Y, Yang C, Zhang Z, Jiang H. Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways. Front Oncol 2021;11:679712. [PMID: 34221998 DOI: 10.3389/fonc.2021.679712] [Reference Citation Analysis]
323 Richards GHC, Hong KL, Henein MY, Hanratty C, Boles U. Coronary Artery Ectasia: Review of the Non-Atherosclerotic Molecular and Pathophysiologic Concepts. IJMS 2022;23:5195. [DOI: 10.3390/ijms23095195] [Reference Citation Analysis]
324 Li H, Liu F, Lu J, Shi J, Guan J, Yan F, Li B, Huo G. Probiotic Mixture of Lactobacillus plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice.Front Microbiol. 2020;11:512. [PMID: 32273874 DOI: 10.3389/fmicb.2020.00512] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
325 Mukherjee A, Lordan C, Ross RP, Cotter PD. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes 2020;12:1802866. [PMID: 32835590 DOI: 10.1080/19490976.2020.1802866] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
326 Tabata T, Yamashita T, Hosomi K, Park J, Hayashi T, Yoshida N, Saito Y, Fukuzawa K, Konishi K, Murakami H, Kawashima H, Mizuguchi K, Miyachi M, Kunisawa J, Hirata KI. Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs. Heart Vessels 2021;36:105-14. [PMID: 32683492 DOI: 10.1007/s00380-020-01669-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
327 Wu J, Li K, Peng W, Li H, Li Q, Wang X, Peng Y, Tang X, Fu X. Autoinducer-2 of Fusobacterium nucleatum promotes macrophage M1 polarization via TNFSF9/IL-1β signaling. Int Immunopharmacol 2019;74:105724. [PMID: 31272064 DOI: 10.1016/j.intimp.2019.105724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
328 Xia J, Jiang S, Lv L, Wu W, Wang Q, Xu Q, Ye J, Fang D, Li Y, Wu J, Bian X, Yang L, Jiang H, Wang K, Yan R, Li L. Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI01. Appl Microbiol Biotechnol 2021;105:1629-45. [PMID: 33507355 DOI: 10.1007/s00253-021-11099-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
329 Bartolomaeus H, Markó L, Wilck N, Luft FC, Forslund SK, Muller DN. Precarious Symbiosis Between Host and Microbiome in Cardiovascular Health. Hypertension 2019;73:926-35. [PMID: 30905198 DOI: 10.1161/HYPERTENSIONAHA.119.11786] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
330 Ottosson F, Brunkwall L, Smith E, Orho-Melander M, Nilsson PM, Fernandez C, Melander O. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease. J Hypertens 2020;38:2427-34. [PMID: 32665522 DOI: 10.1097/HJH.0000000000002569] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
331 Vourakis M, Mayer G, Rousseau G. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis. Int J Mol Sci 2021;22:8074. [PMID: 34360839 DOI: 10.3390/ijms22158074] [Reference Citation Analysis]
332 Marfil-Sánchez A, Zhang L, Alonso-Pernas P, Mirhakkak M, Mueller M, Seelbinder B, Ni Y, Santhanam R, Busch A, Beemelmanns C, Ermolaeva M, Bauer M, Panagiotou G. An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness. Gut Microbes 2021;13:1993598. [PMID: 34793277 DOI: 10.1080/19490976.2021.1993598] [Reference Citation Analysis]
333 Luo Y, Fang J, Yuan K, Jin S, Guo Y. Ameliorative effect of purified anthocyanin from Lycium ruthenicum on atherosclerosis in rats through synergistic modulation of the gut microbiota and NF-κB/SREBP-2 pathways. Journal of Functional Foods 2019;59:223-33. [DOI: 10.1016/j.jff.2019.05.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
334 Dahl WJ, Rivero Mendoza D, Lambert JM. Diet, nutrients and the microbiome. Prog Mol Biol Transl Sci 2020;171:237-63. [PMID: 32475524 DOI: 10.1016/bs.pmbts.2020.04.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
335 Trøseid M, Andersen GØ, Broch K, Hov JR. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine 2020;52:102649. [PMID: 32062353 DOI: 10.1016/j.ebiom.2020.102649] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
336 Lu H, Lou H, Hu J, Liu Z, Chen Q. Macrofungi: A review of cultivation strategies, bioactivity, and application of mushrooms. Comprehensive Reviews in Food Science and Food Safety 2020;19:2333-56. [DOI: 10.1111/1541-4337.12602] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
337 Gesper M, Nonnast ABH, Kumowski N, Stoehr R, Schuett K, Marx N, Kappel BA. Gut-Derived Metabolite Indole-3-Propionic Acid Modulates Mitochondrial Function in Cardiomyocytes and Alters Cardiac Function. Front Med (Lausanne) 2021;8:648259. [PMID: 33829028 DOI: 10.3389/fmed.2021.648259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
338 Diener C, Reyes-Escogido ML, Jimenez-Ceja LM, Matus M, Gomez-Navarro CM, Chu ND, Zhong V, Tejero ME, Alm E, Resendis-Antonio O, Guardado-Mendoza R. Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort. Front Endocrinol (Lausanne) 2020;11:602326. [PMID: 33488518 DOI: 10.3389/fendo.2020.602326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L, Gao X, Zhu B, Lei XG, Gu Z, Cui W, Xu X, Li Z, Zhu B, Li Y, Chen S, Guo H, Zhang H, Sun J, Zhang M, Hui Y, Zhang X, Liu X, Sun B, Wang L, Qiu Q, Zhang Y, Li X, Liu W, Xue R, Wu H, Shao D, Li J, Zhou Y, Li S, Yang R, Pedersen OB, Yu Z, Ehrlich SD, Ren F. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 2020;69:2131-42. [PMID: 32241904 DOI: 10.1136/gutjnl-2019-319766] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
340 Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut Microbiota and Immune System Interactions.Microorganisms. 2020;8. [PMID: 33076307 DOI: 10.3390/microorganisms8101587] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
341 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies. Gastroenterology 2021;160:573-99. [PMID: 33253685 DOI: 10.1053/j.gastro.2020.10.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
342 Jaago M, Pupina N, Rähni A, Pihlak A, Sadam H, Vrana NE, Sinisalo J, Pussinen P, Palm K. Antibody response to oral biofilm is a biomarker for acute coronary syndrome in periodontal disease. Commun Biol 2022;5:205. [PMID: 35246599 DOI: 10.1038/s42003-022-03122-4] [Reference Citation Analysis]
343 Hassan A, Din AU, Zhu Y, Zhang K, Li T, Wang Y, Xu S, Lei H, Yu X, Wang G. Anti-atherosclerotic effects of Lactobacillus plantarum ATCC 14917 in ApoE-/- mice through modulation of proinflammatory cytokines and oxidative stress. Appl Microbiol Biotechnol 2020;104:6337-50. [PMID: 32472174 DOI: 10.1007/s00253-020-10693-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
344 Coker JK, Moyne O, Rodionov DA, Zengler K. Carbohydrates great and small, from dietary fiber to sialic acids: How glycans influence the gut microbiome and affect human health. Gut Microbes 2021;13:1-18. [PMID: 33615984 DOI: 10.1080/19490976.2020.1869502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
345 Li Z, Lu G, Li Z, Wu B, Luo E, Qiu X, Guo J, Xia Z, Zheng C, Su Q, Zeng Y, Chan WY, Su X, Cai Q, Xu Y, Chen Y, Wang M, Poon WS, Luo X. Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease. Front Immunol 2021;12:632482. [PMID: 34276644 DOI: 10.3389/fimmu.2021.632482] [Reference Citation Analysis]
346 Vojinovic D, Radjabzadeh D, Kurilshikov A, Amin N, Wijmenga C, Franke L, Ikram MA, Uitterlinden AG, Zhernakova A, Fu J, Kraaij R, van Duijn CM. Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nat Commun 2019;10:5813. [PMID: 31862950 DOI: 10.1038/s41467-019-13721-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 15.3] [Reference Citation Analysis]
347 Yoshida N, Yamashita T, Kishino S, Watanabe H, Sasaki K, Sasaki D, Tabata T, Sugiyama Y, Kitamura N, Saito Y, Emoto T, Hayashi T, Takahashi T, Shinohara M, Osawa R, Kondo A, Yamada T, Ogawa J, Hirata KI. A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases. Sci Rep 2020;10:13009. [PMID: 32747669 DOI: 10.1038/s41598-020-69983-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
348 Kraemer SA, Ramachandran A, Perron GG. Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy. Microorganisms 2019;7:E180. [PMID: 31234491 DOI: 10.3390/microorganisms7060180] [Cited by in Crossref: 159] [Cited by in F6Publishing: 107] [Article Influence: 53.0] [Reference Citation Analysis]
349 Brandsma E, Kloosterhuis NJ, Koster M, Dekker DC, Gijbels MJJ, van der Velden S, Ríos-Morales M, van Faassen MJR, Loreti MG, de Bruin A, Fu J, Kuipers F, Bakker BM, Westerterp M, de Winther MPJ, Hofker MH, van de Sluis B, Koonen DPY. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis. Circ Res 2019;124:94-100. [PMID: 30582442 DOI: 10.1161/CIRCRESAHA.118.313234] [Cited by in Crossref: 71] [Cited by in F6Publishing: 40] [Article Influence: 23.7] [Reference Citation Analysis]
350 Tindall AM, Petersen KS, Kris-Etherton PM. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases. J Nutr 2018;148:1402-7. [PMID: 30184227 DOI: 10.1093/jn/nxy141] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
351 Ravid JD, Kamel MH, Chitalia VC. Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease. Nat Rev Nephrol 2021;17:402-16. [PMID: 33758363 DOI: 10.1038/s41581-021-00408-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
352 Li M, Cheng A, Sun J, Fan C, Meng R. The role of urinary albumin-to-creatinine ratio as a biomarker to predict stroke: A meta-analysis and systemic review. Brain Circ 2021;7:139-46. [PMID: 34667897 DOI: 10.4103/bc.bc_64_20] [Reference Citation Analysis]
353 Bourgi K, Wanjalla C, Koethe JR. Inflammation and Metabolic Complications in HIV. Curr HIV/AIDS Rep 2018;15:371-81. [PMID: 30058057 DOI: 10.1007/s11904-018-0411-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
354 Anlu W, Dongcheng C, He Z, Qiuyi L, Yan Z, Yu Q, Hao X, Keji C. Using herbal medicine to target the “microbiota-metabolism-immunity” axis as possible therapy for cardiovascular disease. Pharmacological Research 2019;142:205-22. [DOI: 10.1016/j.phrs.2019.02.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
355 Clifford AH, Cohen Tervaert JW. Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis. Atherosclerosis 2021;325:8-15. [PMID: 33873090 DOI: 10.1016/j.atherosclerosis.2021.03.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Künstner A, Aherrahrou R, Hirose M, Bruse P, Ibrahim SM, Busch H, Erdmann J, Aherrahrou Z. Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background. Cells 2021;10:1292. [PMID: 34070975 DOI: 10.3390/cells10061292] [Reference Citation Analysis]
357 Zeibich L, Koebele SV, Bernaud VE, Ilhan ZE, Dirks B, Northup-Smith SN, Neeley R, Maldonado J, Nirmalkar K, Files JA, Mayer AP, Bimonte-Nelson HA, Krajmalnik-Brown R. Surgical Menopause and Estrogen Therapy Modulate the Gut Microbiota, Obesity Markers, and Spatial Memory in Rats. Front Cell Infect Microbiol 2021;11:702628. [PMID: 34660336 DOI: 10.3389/fcimb.2021.702628] [Reference Citation Analysis]
358 Carbone F, Bonaventura A, Liberale L, Paolino S, Torre F, Dallegri F, Montecucco F, Cutolo M. Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents. Clin Rev Allergy Immunol 2020;58:1-14. [PMID: 30259381 DOI: 10.1007/s12016-018-8714-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
359 Yu H, Yu Z, Huang H, Li P, Tang Q, Wang X, Shen S. Gut microbiota signatures and lipids metabolism profiles by exposure to polyene phosphatidylcholine. BioFactors 2019;45:439-49. [DOI: 10.1002/biof.1495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
360 Bu J, Wang Z. Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity. Gastroenterol Res Pract. 2018;2018:6458094. [PMID: 29967639 DOI: 10.1155/2018/6458094] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
361 He S, Jiang H, Zhuo C, Jiang W. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases. Cardiovasc Toxicol 2021;21:593-604. [PMID: 34003426 DOI: 10.1007/s12012-021-09656-z] [Reference Citation Analysis]
362 He M, Tan C, Xu Y, Liu Y. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease? Food Research International 2020;138:109812. [DOI: 10.1016/j.foodres.2020.109812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
363 Lee SY, Lee DY, Kang HJ, Kang JH, Cho MG, Jang HW, Kim BK, Hur SJ. Differences in the gut microbiota between young and elderly persons in Korea. Nutr Res 2021;87:31-40. [PMID: 33596509 DOI: 10.1016/j.nutres.2020.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
364 Chang TT, Chen JW. Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus. J Inflamm Res 2021;14:6237-50. [PMID: 34866923 DOI: 10.2147/JIR.S343491] [Reference Citation Analysis]
365 Cao RY, Zhang Y, Feng Z, Liu S, Liu Y, Zheng H, Yang J. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Front Pharmacol 2021;12:764994. [PMID: 35002703 DOI: 10.3389/fphar.2021.764994] [Reference Citation Analysis]
366 Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients 2020;12:E2982. [PMID: 33003455 DOI: 10.3390/nu12102982] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
367 Caro-Gómez E, Sierra JA, Escobar JS, Álvarez-Quintero R, Naranjo M, Medina S, Velásquez-Mejía EP, Tabares-Guevara JH, Jaramillo JC, León-Varela YM, Muñoz-Durango K, Ramírez-Pineda JR. Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice. Nutrients 2019;11:E497. [PMID: 30818779 DOI: 10.3390/nu11030497] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
368 Stott KJ, Phillips B, Parry L, May S. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer. Biosci Rep 2021:BSR20204113. [PMID: 34236075 DOI: 10.1042/BSR20204113] [Reference Citation Analysis]
369 Liao HY, Wang CY, Lee CH, Kao HL, Wu WK, Kuo CH. Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease. J Proteome Res 2021;20:3508-18. [PMID: 34053222 DOI: 10.1021/acs.jproteome.1c00147] [Reference Citation Analysis]
370 Yang G, Wei J, Liu P, Zhang Q, Tian Y, Hou G, Meng L, Xin Y, Jiang X. Role of the gut microbiota in type 2 diabetes and related diseases. Metabolism 2021;117:154712. [PMID: 33497712 DOI: 10.1016/j.metabol.2021.154712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
371 Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C. The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan. Int Urol Nephrol 2020;52:1421-8. [PMID: 32193686 DOI: 10.1007/s11255-020-02443-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Ferrell M, Bazeley P, Wang Z, Levison BS, Li XS, Jia X, Krauss RM, Knight R, Lusis AJ, Garcia-Garcia JC, Hazen SL, Tang WHW. Fecal Microbiome Composition Does Not Predict Diet-Induced TMAO Production in Healthy Adults. J Am Heart Assoc 2021;10:e021934. [PMID: 34713713 DOI: 10.1161/JAHA.121.021934] [Reference Citation Analysis]
373 Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, Ceglarek U, Cineus R, Hegazy AN, van der Vorst EPC, Döring Y, Strauch CM, Nemet I, Tremaroli V, Dwibedi C, Kränkel N, Leistner DM, Heimesaat MM, Bereswill S, Rauch G, Seeland U, Soehnlein O, Müller DN, Gold R, Bäckhed F, Hazen SL, Haghikia A, Landmesser U. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur Heart J 2021:ehab644. [PMID: 34597388 DOI: 10.1093/eurheartj/ehab644] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
374 Martino C, Morton JT, Marotz CA, Thompson LR, Tripathi A, Knight R, Zengler K. A Novel Sparse Compositional Technique Reveals Microbial Perturbations. mSystems 2019;4:e00016-19. [PMID: 30801021 DOI: 10.1128/mSystems.00016-19] [Cited by in Crossref: 89] [Cited by in F6Publishing: 48] [Article Influence: 29.7] [Reference Citation Analysis]
375 Wilson BC, Vatanen T, Cutfield WS, O'Sullivan JM. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019;9:2. [PMID: 30719428 DOI: 10.3389/fcimb.2019.00002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 39.0] [Reference Citation Analysis]
376 Harikrishnan S. Diet, the Gut Microbiome and Heart Failure. Card Fail Rev 2019;5:119-22. [PMID: 31179023 DOI: 10.15420/cfr.2018.39.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
377 Matsumoto T, Takayanagi K, Kojima M, Taguchi K, Kobayashi T. Acute Exposure to Indoxyl Sulfate Impairs Endothelium-Dependent Vasorelaxation in Rat Aorta. Int J Mol Sci 2019;20:E338. [PMID: 30650577 DOI: 10.3390/ijms20020338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
378 Mattioli AV, Coppi F, Manenti A, Farinetti A. Subclinical Vascular Damage: Current Insights and Future Potential. Vasc Health Risk Manag 2021;17:729-38. [PMID: 34866906 DOI: 10.2147/VHRM.S242636] [Reference Citation Analysis]
379 Ford AL, Nagulesapillai V, Piano A, Auger J, Girard SA, Christman M, Tompkins TA, Dahl WJ. Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women. J Acad Nutr Diet 2020;120:500-516.e10. [PMID: 32199523 DOI: 10.1016/j.jand.2019.12.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
380 Łykowska-Szuber L, Rychter AM, Dudek M, Ratajczak AE, Szymczak-Tomczak A, Zawada A, Eder P, Lesiak M, Dobrowolska A, Krela-Kaźmierczak I. What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review. Nutrients 2021;13:2661. [PMID: 34444821 DOI: 10.3390/nu13082661] [Reference Citation Analysis]
381 Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine 2019;66:526-37. [DOI: 10.1007/s12020-019-02103-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
382 Kriaa A, Bourgin M, Potiron A, Mkaouar H, Jablaoui A, Gérard P, Maguin E, Rhimi M. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res 2019;60:323-32. [PMID: 30487175 DOI: 10.1194/jlr.R088989] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 14.3] [Reference Citation Analysis]
383 Wu M, Yang S, Wang S, Cao Y, Zhao R, Li X, Xing Y, Liu L. Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. Front Pharmacol 2020;11:223. [PMID: 32231564 DOI: 10.3389/fphar.2020.00223] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
384 Bai X, Wang WX, Fu RJ, Yue SJ, Gao H, Chen YY, Tang YP. Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases. Front Pharmacol 2020;11:01265. [PMID: 33117148 DOI: 10.3389/fphar.2020.01265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
385 Docimo G, Cangiano A, Romano RM, Pignatelli MF, Offi C, Paglionico VA, Galdiero M, Donnarumma G, Nigro V, Esposito D, Rotondi M, Candela G, Pasquali D. The Human Microbiota in Endocrinology: Implications for Pathophysiology, Treatment, and Prognosis in Thyroid Diseases. Front Endocrinol (Lausanne) 2020;11:586529. [PMID: 33343507 DOI: 10.3389/fendo.2020.586529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
386 Roswall J, Olsson LM, Kovatcheva-Datchary P, Nilsson S, Tremaroli V, Simon MC, Kiilerich P, Akrami R, Krämer M, Uhlén M, Gummesson A, Kristiansen K, Dahlgren J, Bäckhed F. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe 2021;29:765-776.e3. [PMID: 33794185 DOI: 10.1016/j.chom.2021.02.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
387 Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A. Blood Microbiome Profile in CKD : A Pilot Study. Clin J Am Soc Nephrol 2019;14:692-701. [PMID: 30962186 DOI: 10.2215/CJN.12161018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 8.7] [Reference Citation Analysis]
388 Li RJ, Jie ZY, Feng Q, Fang RL, Li F, Gao Y, Xia HH, Zhong HZ, Tong B, Madsen L, Zhang JH, Liu CL, Xu ZG, Wang J, Yang HM, Xu X, Hou Y, Brix S, Kristiansen K, Yu XL, Jia HJ, He KL. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis. Front Cell Infect Microbiol 2021;11:708088. [PMID: 34692558 DOI: 10.3389/fcimb.2021.708088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Li J, Li Y, Ivey KL, Wang DD, Wilkinson JE, Franke A, Lee KH, Chan A, Huttenhower C, Hu FB, Rimm EB, Sun Q. Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: findings from a longitudinal cohort of US men. Gut 2021:gutjnl-2020-322473. [PMID: 33926968 DOI: 10.1136/gutjnl-2020-322473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
390 Chang CS, Kao CY. Current understanding of the gut microbiota shaping mechanisms. J Biomed Sci 2019;26:59. [PMID: 31434568 DOI: 10.1186/s12929-019-0554-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
391 Walker RL, Vlamakis H, Lee JWJ, Besse LA, Xanthakis V, Vasan RS, Shaw SY, Xavier RJ. Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease. Genome Med 2021;13:188. [PMID: 34915914 DOI: 10.1186/s13073-021-01007-5] [Reference Citation Analysis]
392 Chen H, Li DH, Jiang AJ, Li XG, Wu SJ, Chen JW, Qu MJ, Qi XQ, Dai J, Zhao R, Zhang W, Liu SS, Wu L. Metagenomic analysis reveals wide distribution of phototrophic bacteria in hydrothermal vents on the ultraslow-spreading Southwest Indian Ridge. Mar Life Sci Technol. [DOI: 10.1007/s42995-021-00121-y] [Reference Citation Analysis]
393 Khandouzi N, Zahedmehr A, Firoozi A, Nasrollahzadehp J. Effects of flaxseed consumption on plasma lipids, lipoprotein-associated phospholipase A2 activity and gut microbiota composition in patients with coronary artery disease. Nutr Health 2022;:2601060221091016. [PMID: 35382631 DOI: 10.1177/02601060221091016] [Reference Citation Analysis]
394 Phillippi DT, Daniel S, Pusadkar V, Youngblood VL, Nguyen KN, Azad RK, McFarlin BK, Lund AK. Inhaled diesel exhaust particles result in microbiome-related systemic inflammation and altered cardiovascular disease biomarkers in C57Bl/6 male mice. Part Fibre Toxicol 2022;19:10. [PMID: 35135577 DOI: 10.1186/s12989-022-00452-3] [Reference Citation Analysis]
395 Li Q, Ren Y, Fu X. Inter-kingdom signaling between gut microbiota and their host. Cell Mol Life Sci 2019;76:2383-9. [PMID: 30911771 DOI: 10.1007/s00018-019-03076-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
396 Quareshy M, Shanmugam M, Townsend E, Jameson E, Bugg TDH, Cameron AD, Chen Y. Structural basis of carnitine monooxygenase CntA substrate specificity, inhibition, and intersubunit electron transfer. J Biol Chem 2021;296:100038. [PMID: 33158989 DOI: 10.1074/jbc.RA120.016019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
397 Minnifield BA, Aslibekyan SW. The Interplay Between the Microbiome and Cardiovascular Risk. Curr Genet Med Rep 2018;6:89-97. [DOI: 10.1007/s40142-018-0142-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
398 Li H, Liu B, Song J, An Z, Zeng X, Li J, Jiang J, Xie L, Wu W. Characteristics of Gut Microbiota in Patients with Hypertension and/or Hyperlipidemia: A Cross-Sectional Study on Rural Residents in Xinxiang County, Henan Province. Microorganisms 2019;7:E399. [PMID: 31561625 DOI: 10.3390/microorganisms7100399] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
399 Zhang X, Zhang X, Tong F, Cai Y, Zhang Y, Song H, Tian X, Yan C, Han Y. Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment. Elife 2022;11:e70240. [PMID: 35258452 DOI: 10.7554/eLife.70240] [Reference Citation Analysis]
400 Yeh CF, Chen YH, Liu SF, Kao HL, Wu MS, Yang KC, Wu WK. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis. Int J Mol Sci 2020;21:E8729. [PMID: 33227973 DOI: 10.3390/ijms21228729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
401 Wu PH, Liu PY, Chiu YW, Hung WC, Lin YT, Lin TY, Hung SC, Delicano RA, Kuo MC, Wu CY. Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease. Microorganisms 2020;8:E2040. [PMID: 33419265 DOI: 10.3390/microorganisms8122040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
402 Borg MJ, Rayner CK, Jones KL, Horowitz M, Xie C, Wu T. Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin. Pharmaceuticals (Basel) 2020;13:E410. [PMID: 33266396 DOI: 10.3390/ph13110410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
403 Liu X, Shen M, Yan H, Long P, Jiang H, Zhang Y, Zhou L, Yu K, Qiu G, Yang H, Li X, Min X, He M, Zhang X, Choi H, Wang C, Wu T. Alternations in the gut microbiota and metabolome with newly diagnosed unstable angina. J Genet Genomics 2021:S1673-8527(21)00362-3. [PMID: 34883258 DOI: 10.1016/j.jgg.2021.11.009] [Reference Citation Analysis]
404 Zhao Y, Wang Z. Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease. J Lab Precis Med 2020;5:16. [PMID: 32587943 DOI: 10.21037/jlpm.2020.01.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
405 van Son J, Serlie MJ, Ståhlman M, Bäckhed F, Nieuwdorp M, Aron-Wisnewsky J. Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans. Nutrients 2021;13:2706. [PMID: 34444866 DOI: 10.3390/nu13082706] [Reference Citation Analysis]
406 Liu X, Tang S, Zhong H, Tong X, Jie Z, Ding Q, Wang D, Guo R, Xiao L, Xu X, Yang H, Wang J, Zong Y, Liu W, Liu X, Zhang Y, Brix S, Kristiansen K, Hou Y, Jia H, Zhang T. A genome-wide association study for gut metagenome in Chinese adults illuminates complex diseases. Cell Discov 2021;7:9. [PMID: 33563976 DOI: 10.1038/s41421-020-00239-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
407 Myhrstad MCW, Tunsjø H, Charnock C, Telle-Hansen VH. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials. Nutrients 2020;12:E859. [PMID: 32210176 DOI: 10.3390/nu12030859] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
408 Korach-Rechtman H, Rom O, Mazouz L, Freilich S, Jeries H, Hayek T, Aviram M, Kashi Y. Soybean Oil Modulates the Gut Microbiota Associated with Atherogenic Biomarkers. Microorganisms 2020;8:E486. [PMID: 32235412 DOI: 10.3390/microorganisms8040486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
409 Ho A, Sinick J, Esko T, Fischer K, Menni C, Zierer J, Matey-Hernandez M, Fortney K, Morgen EK. Circulating glucuronic acid predicts healthspan and longevity in humans and mice. Aging (Albany NY) 2019;11:7694-706. [PMID: 31557729 DOI: 10.18632/aging.102281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
410 Arora V, Singh G, O-Sullivan I, Ma K, Natarajan Anbazhagan A, Votta-Velis EG, Bruce B, Richard R, van Wijnen AJ, Im HJ. Gut-microbiota modulation: The impact of thegut-microbiotaon osteoarthritis. Gene 2021;785:145619. [PMID: 33781857 DOI: 10.1016/j.gene.2021.145619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
411 Yamashita T, Yoshida N, Emoto T, Saito Y, Hirata KI. Two Gut Microbiota-Derived Toxins Are Closely Associated with Cardiovascular Diseases: A Review. Toxins (Basel) 2021;13:297. [PMID: 33921975 DOI: 10.3390/toxins13050297] [Reference Citation Analysis]
412 Duttaroy AK. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review. Nutrients 2021;13:E144. [PMID: 33401598 DOI: 10.3390/nu13010144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
413 Osman MM, El-khatib FM, Roberts NH, Huynh LM, Yafi FA. The Gut Microbiome and Men’s Sexual Health. Curr Sex Health Rep 2019;11:348-57. [DOI: 10.1007/s11930-019-00230-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
414 Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front Immunol 2018;9:586. [PMID: 29686666 DOI: 10.3389/fimmu.2018.00586] [Cited by in Crossref: 283] [Cited by in F6Publishing: 277] [Article Influence: 70.8] [Reference Citation Analysis]
415 Kott KA, Vernon ST, Hansen T, de Dreu M, Das SK, Powell J, Fazekas de St Groth B, Di Bartolo BA, McGuire HM, Figtree GA. Single-Cell Immune Profiling in Coronary Artery Disease: The Role of State-of-the-Art Immunophenotyping With Mass Cytometry in the Diagnosis of Atherosclerosis. J Am Heart Assoc 2020;9:e017759. [PMID: 33251927 DOI: 10.1161/JAHA.120.017759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
416 Liu J, Li Y, Feng Y, Pan L, Xie Z, Yan Z, Zhang L, Li M, Zhao J, Sun J, Hong L. Patterned progression of gut microbiota associated with necrotizing enterocolitis and late onset sepsis in preterm infants: a prospective study in a Chinese neonatal intensive care unit. PeerJ 2019;7:e7310. [PMID: 31367483 DOI: 10.7717/peerj.7310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
417 Jie Z, Liang S, Ding Q, Li F, Tang S, Wang D, Lin Y, Chen P, Cai K, Qiu X, Li Q, Liao Y, Zhou D, Lian H, Zuo Y, Chen X, Rao W, Ren Y, Wang Y, Zi J, Wang R, Zhou H, Lu H, Wang X, Zhang W, Zhang T, Xiao L, Zong Y, Liu W, Yang H, Wang J, Hou Y, Liu X, Kristiansen K, Zhong H, Jia H, Xu X. A transomic cohort as a reference point for promoting a healthy human gut microbiome. Medicine in Microecology 2021;8:100039. [DOI: 10.1016/j.medmic.2021.100039] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
418 Fernandez DM, Clemente JC, Giannarelli C. Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease. Front Physiol 2018;9:763. [PMID: 30013482 DOI: 10.3389/fphys.2018.00763] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
419 Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y, Zhang X, Yang R, Jiang R, Xu Y, Qin H. Dysbiosis signatures of gut microbiota in coronary artery disease. Physiological Genomics 2018;50:893-903. [DOI: 10.1152/physiolgenomics.00070.2018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
420 Ravichandran AN, Ramuz M, Blayac S. Increasing surface charge density by effective charge accumulation layer inclusion for high-performance triboelectric nanogenerators. MRS Communications 2019;9:682-9. [DOI: 10.1557/mrc.2019.64] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
421 Shanmugam M, Quareshy M, Cameron AD, Bugg TDH, Chen Y. Light-Activated Electron Transfer and Catalytic Mechanism of Carnitine Oxidation by Rieske-Type Oxygenase from Human Microbiota. Angew Chem Int Ed Engl 2021;60:4529-34. [PMID: 33180358 DOI: 10.1002/anie.202012381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
422 Gallardo-Escárate C, Valenzuela-Muñoz V, Núñez-Acuña G, Valenzuela-Miranda D, Benaventel BP, Sáez-Vera C, Urrutia H, Novoa B, Figueras A, Roberts S, Assmann P, Bravo M. The wastewater microbiome: A novel insight for COVID-19 surveillance. Sci Total Environ 2021;764:142867. [PMID: 33071116 DOI: 10.1016/j.scitotenv.2020.142867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
423 Zheng Z, Aweya JJ, Bao S, Yao D, Li S, Tran NT, Ma H, Zhang Y. The Microbial Composition of Penaeid Shrimps' Hepatopancreas Is Modulated by Hemocyanin. J Immunol 2021;207:2733-43. [PMID: 34670821 DOI: 10.4049/jimmunol.2100746] [Reference Citation Analysis]
424 Ahmad AF, Dwivedi G, O'Gara F, Caparros-Martin J, Ward NC. The gut microbiome and cardiovascular disease: current knowledge and clinical potential. Am J Physiol Heart Circ Physiol 2019;317:H923-38. [PMID: 31469291 DOI: 10.1152/ajpheart.00376.2019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
425 Corwin EJ, Brewster G, Dunbar SB, Wells J, Hertzberg V, Holstad M, Song MK, Jones D. The Metabolomic Underpinnings of Symptom Burden in Patients With Multiple Chronic Conditions. Biol Res Nurs 2021;23:270-9. [PMID: 32914645 DOI: 10.1177/1099800420958196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
426 Liu Z, Ma A, Mathé E, Merling M, Ma Q, Liu B. Network analyses in microbiome based on high-throughput multi-omics data. Brief Bioinform 2021;22:1639-55. [PMID: 32047891 DOI: 10.1093/bib/bbaa005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
427 Breuninger TA, Wawro N, Breuninger J, Reitmeier S, Clavel T, Six-Merker J, Pestoni G, Rohrmann S, Rathmann W, Peters A, Grallert H, Meisinger C, Haller D, Linseisen J. Associations between habitual diet, metabolic disease, and the gut microbiota using latent Dirichlet allocation. Microbiome 2021;9:61. [PMID: 33726846 DOI: 10.1186/s40168-020-00969-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
428 Yoshimoto S, Mitsuyama E, Yoshida K, Odamaki T, Xiao JZ. Enriched metabolites that potentially promote age-associated diseases in subjects with an elderly-type gut microbiota. Gut Microbes 2021;13:1-11. [PMID: 33430687 DOI: 10.1080/19490976.2020.1865705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
429 Tarracchini C, Fontana F, Lugli GA, Mancabelli L, Alessandri G, Turroni F, Ventura M, Milani C. Investigation of the Ecological Link between Recurrent Microbial Human Gut Communities and Physical Activity. Microbiol Spectr 2022;:e0042022. [PMID: 35377222 DOI: 10.1128/spectrum.00420-22] [Reference Citation Analysis]
430 Okuyama Y, Okamoto T, Sasaki D, Ozaki K, Songee J, Hatakeyama S, Mikami T, Ohyama C. The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan. Int Urol Nephrol 2021. [PMID: 34714460 DOI: 10.1007/s11255-021-03044-w] [Reference Citation Analysis]
431 Dam B, Misra A, Banerjee S. Role of Gut Microbiota in Combating Oxidative Stress. In: Chakraborti S, Chakraborti T, Chattopadhyay D, Shaha C, editors. Oxidative Stress in Microbial Diseases. Singapore: Springer; 2019. pp. 43-82. [DOI: 10.1007/978-981-13-8763-0_4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
432 Han Q, Wang J, Li W, Chen ZJ, Du Y. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome. Microbiome 2021;9:101. [PMID: 33957990 DOI: 10.1186/s40168-021-01046-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
433 Oynotkinova OS, Nikonov EL, Demidova TY, Baranov AP, Kryukov EV, Dedov EI, Karavashkina EA. [Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention]. Ter Arkh 2020;92:94-101. [PMID: 33346437 DOI: 10.26442/00403660.2020.09.000784] [Reference Citation Analysis]
434 Battey JND, Szostak J, Phillips B, Teng C, Tung CK, Lim WT, Yeo YS, Ouadi S, Baumer K, Thomas J, Martinis J, Sierro N, Ivanov NV, Vanscheeuwijck P, Peitsch MC, Hoeng J. Impact of 6-Month Exposure to Aerosols From Potential Modified Risk Tobacco Products Relative to Cigarette Smoke on the Rodent Gastrointestinal Tract. Front Microbiol 2021;12:587745. [PMID: 34276574 DOI: 10.3389/fmicb.2021.587745] [Reference Citation Analysis]
435 Kwun JS, Kang SH, Lee HJ, Park HK, Lee WJ, Yoon CH, Suh JW, Cho YS, Youn TJ, Chae IH. Comparison of thrombus, gut, and oral microbiomes in Korean patients with ST-elevation myocardial infarction: a case-control study. Exp Mol Med 2020;52:2069-79. [PMID: 33339953 DOI: 10.1038/s12276-020-00543-1] [Reference Citation Analysis]
436 Balvers M, van den Born BH, Levin E, Nieuwdorp M. Impact drugs targeting cardiometabolic risk on the gut microbiota. Curr Opin Lipidol 2021;32:38-54. [PMID: 33332920 DOI: 10.1097/MOL.0000000000000727] [Reference Citation Analysis]
437 Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res 2021;164:105277. [PMID: 33166735 DOI: 10.1016/j.phrs.2020.105277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
438 Liu X, Cheng Y, Zang D, Zhang M, Li X, Liu D, Gao B, Zhou H, Sun J, Han X, Lin M, Chen J. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy. Front Oncol 2021;11:720842. [PMID: 34490119 DOI: 10.3389/fonc.2021.720842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
439 Wu S, Cong G, Zhang Q, Yao H, Wang Z, Kang K, He X, Shi S. Infection Heterogeneity and Microbiota Differences in Chicks Infected by Salmonella enteritidis. Microorganisms 2021;9:1705. [PMID: 34442784 DOI: 10.3390/microorganisms9081705] [Reference Citation Analysis]
440 Madan S, Mehra MR. Gut dysbiosis and heart failure: navigating the universe within. Eur J Heart Fail 2020;22:629-37. [DOI: 10.1002/ejhf.1792] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
441 Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and Colorectal Cancer. Front Oncol. 2018;8:371. [PMID: 30374420 DOI: 10.3389/fonc.2018.00371] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
442 Qin Q, Yan S, Yang Y, Chen J, Li T, Gao X, Yan H, Wang Y, Wang J, Wang S, Ding S. A Metagenome-Wide Association Study of the Gut Microbiome and Metabolic Syndrome. Front Microbiol 2021;12:682721. [PMID: 34335505 DOI: 10.3389/fmicb.2021.682721] [Reference Citation Analysis]
443 Fernandes MF, de Oliveira S, Portovedo M, Rodrigues PB, Vinolo MAR. Effect of Short Chain Fatty Acids on Age-Related Disorders. Adv Exp Med Biol 2020;1260:85-105. [PMID: 32304031 DOI: 10.1007/978-3-030-42667-5_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
444 Huang Z, Hou D, Zhou R, Zeng S, Xing C, Wei D, Deng X, Yu L, Wang H, Deng Z, Weng S, Ning D, Xiao C, Yan Q, Zhou J, He Z, He J. Environmental Water and Sediment Microbial Communities Shape Intestine Microbiota for Host Health: The Central Dogma in an Anthropogenic Aquaculture Ecosystem. Front Microbiol 2021;12:772149. [PMID: 34795658 DOI: 10.3389/fmicb.2021.772149] [Reference Citation Analysis]
445 Yang L, Wang T, Zhang X, Zhang H, Yan N, Zhang G, Yan R, Li Y, Yu J, He J, Jia S, Wang H. Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis. BMC Cardiovasc Disord 2022;22:61. [PMID: 35172728 DOI: 10.1186/s12872-022-02508-w] [Reference Citation Analysis]
446 Su Z, Lu L, Chen F, Chen J, Chen X. Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study. Cancer Manag Res 2021;13:8663-72. [PMID: 34849023 DOI: 10.2147/CMAR.S328451] [Reference Citation Analysis]
447 Kawulok J, Kawulok M, Deorowicz S. Environmental metagenome classification for constructing a microbiome fingerprint. Biol Direct 2019;14:20. [PMID: 31722729 DOI: 10.1186/s13062-019-0251-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
448 Liu H, Liu H, Liu C, Shang M, Wei T, Yin P. Gut Microbiome and the Role of Metabolites in the Study of Graves’ Disease. Front Mol Biosci 2022;9:841223. [DOI: 10.3389/fmolb.2022.841223] [Reference Citation Analysis]
449 Hong L, Huang H, Wu B. Metabolites of intestinal microflora upregulate microRNA-200c-3p expression level to suppress airway epithelial inflammation via the IL6ST/JNK/STAT3 signaling pathway. Exp Ther Med 2021;22:999. [PMID: 34345281 DOI: 10.3892/etm.2021.10431] [Reference Citation Analysis]
450 Del Pinto R, Pietropaoli D, Monaco A, Desideri G, Ferri C, Grassi D. Non-pharmacological Strategies Against Systemic Inflammation: Molecular Basis and Clinical Evidence. Curr Pharm Des 2020;26:2620-9. [PMID: 32242777 DOI: 10.2174/1381612826666200403122600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
451 de la Cuesta-Zuluaga J, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization. Sci Rep 2018;8:11356. [PMID: 30054529 DOI: 10.1038/s41598-018-29687-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
452 Młynarska E, Gadzinowska J, Tokarek J, Forycka J, Szuman A, Franczyk B, Rysz J. The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder. Nutrients 2022;14:1921. [DOI: 10.3390/nu14091921] [Reference Citation Analysis]
453 Albracht-Schulte K, Islam T, Johnson P, Moustaid-Moussa N. Systematic Review of Beef Protein Effects on Gut Microbiota: Implications for Health. Adv Nutr 2021;12:102-14. [PMID: 32761179 DOI: 10.1093/advances/nmaa085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
454 Nayfach S, Shi ZJ, Seshadri R, Pollard KS, Kyrpides NC. New insights from uncultivated genomes of the global human gut microbiome. Nature 2019;568:505-10. [PMID: 30867587 DOI: 10.1038/s41586-019-1058-x] [Cited by in Crossref: 232] [Cited by in F6Publishing: 163] [Article Influence: 77.3] [Reference Citation Analysis]
455 Currie G, Delles C. Precision Medicine and Personalized Medicine in Cardiovascular Disease. Adv Exp Med Biol 2018;1065:589-605. [PMID: 30051409 DOI: 10.1007/978-3-319-77932-4_36] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
456 Kenny DJ, Plichta DR, Shungin D, Koppel N, Hall AB, Fu B, Vasan RS, Shaw SY, Vlamakis H, Balskus EP, Xavier RJ. Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level. Cell Host Microbe 2020;28:245-257.e6. [PMID: 32544460 DOI: 10.1016/j.chom.2020.05.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
457 Zhao X, Chen Y, Li L, Zhai J, Yu B, Wang H, Yang D, Wang Q, Chang Y, Li J, Zhang P, Zhang H, Li Y. Effect of DLT-SML on Chronic Stable Angina Through Ameliorating Inflammation, Correcting Dyslipidemia, and Regulating Gut Microbiota. J Cardiovasc Pharmacol 2021;77:458-69. [PMID: 33657052 DOI: 10.1097/FJC.0000000000000970] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Hu J, Yao Z, Tang M, Tang C, Zhao X, Su X, Lu D, Li Q, Wang Z, Yan Y, Wang Z. Gut Microbiota Community Shift with Severity of Coronary Artery Disease. Engineering 2021;7:1715-24. [DOI: 10.1016/j.eng.2020.05.025] [Reference Citation Analysis]
459 Mousavi SE, Delgado-Saborit JM, Adivi A, Pauwels S, Godderis L. Air pollution and endocrine disruptors induce human microbiome imbalances: A systematic review of recent evidence and possible biological mechanisms. Sci Total Environ 2021;:151654. [PMID: 34785217 DOI: 10.1016/j.scitotenv.2021.151654] [Reference Citation Analysis]
460 Liptak R, Gromova B, Gardlik R. Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders. Front Med (Lausanne) 2021;8:665520. [PMID: 34557498 DOI: 10.3389/fmed.2021.665520] [Reference Citation Analysis]
461 Yan Q, Zhai W, Yang C, Li Z, Mao L, Zhao M, Wu X. The Relationship among Physical Activity, Intestinal Flora, and Cardiovascular Disease. Cardiovasc Ther 2021;2021:3364418. [PMID: 34729078 DOI: 10.1155/2021/3364418] [Reference Citation Analysis]
462 Chen J, Wang Q, Hao Z, Li Z, Sahu SK, Liu H, Xiao L. Relationship between the Gut Microbiome and Energy/Nutrient Intake in a Confined Bioregenerative Life Support System. Appl Environ Microbiol 2020;86:e02465-19. [PMID: 31811045 DOI: 10.1128/AEM.02465-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
463 Tang WHW, Bäckhed F, Landmesser U, Hazen SL. Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;73:2089-105. [PMID: 31023434 DOI: 10.1016/j.jacc.2019.03.024] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 55.5] [Reference Citation Analysis]
464 Chen L, Ishigami T, Doi H, Arakawa K, Tamura K. Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis. J Mol Med (Berl) 2020;98:1235-44. [PMID: 32737524 DOI: 10.1007/s00109-020-01936-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
465 Ruck CE, Odumade OA, Smolen KK. Vaccine Interactions With the Infant Microbiome: Do They Define Health and Disease? Front Pediatr 2020;8:565368. [PMID: 33324590 DOI: 10.3389/fped.2020.565368] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
466 Kiouptsi K, Reinhardt C. Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis. Br J Pharmacol 2018;175:4439-49. [PMID: 30129122 DOI: 10.1111/bph.14483] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
467 Ahmad AF, Ward NC, Dwivedi G. The gut microbiome and heart failure. Current Opinion in Cardiology 2019;34:225-32. [DOI: 10.1097/hco.0000000000000598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
468 Almeida C, Barata P, Fernandes R. The influence of gut microbiota in cardiovascular diseases-a brief review. Porto Biomed J 2021;6:e106. [PMID: 33490701 DOI: 10.1097/j.pbj.0000000000000106] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
469 Nalbantoglu OU. Information Theoretic Metagenome Assembly Allows the Discovery of Disease Biomarkers in Human Microbiome. Entropy (Basel) 2021;23:187. [PMID: 33540903 DOI: 10.3390/e23020187] [Reference Citation Analysis]
470 Xu S, Zhang X, Liu S, Feng S, Xiang G, Xu C, Fan Z, Xu K, Wang N, Wang Y, Che J, Liu Z, Mu Y, Li K. Multi-Omic Analysis in a Metabolic Syndrome Porcine Model Implicates Arachidonic Acid Metabolism Disorder as a Risk Factor for Atherosclerosis. Front Nutr 2022;9:807118. [DOI: 10.3389/fnut.2022.807118] [Reference Citation Analysis]
471 Ji W, Jiang T, Sun Z, Teng F, Ma C, Huang S, Yan S. The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota. Front Pharmacol 2020;11:546589. [PMID: 33178012 DOI: 10.3389/fphar.2020.546589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
472 Panyod S, Wu W, Chen C, Wu M, Ho C, Sheen L. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine 2021. [DOI: 10.1016/j.jtcme.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Le Roy T, Lécuyer E, Chassaing B, Rhimi M, Lhomme M, Boudebbouze S, Ichou F, Haro Barceló J, Huby T, Guerin M, Giral P, Maguin E, Kapel N, Gérard P, Clément K, Lesnik P. The intestinal microbiota regulates host cholesterol homeostasis. BMC Biol 2019;17:94. [PMID: 31775890 DOI: 10.1186/s12915-019-0715-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
474 Liu L, He X, Feng Y. Coronary heart disease and intestinal microbiota. Coron Artery Dis 2019;30:384-9. [PMID: 31276455 DOI: 10.1097/MCA.0000000000000758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
475 Plaza Oñate F, Le Chatelier E, Almeida M, Cervino ACL, Gauthier F, Magoulès F, Ehrlich SD, Pichaud M. MSPminer: abundance-based reconstitution of microbial pan-genomes from shotgun metagenomic data. Bioinformatics 2019;35:1544-52. [PMID: 30252023 DOI: 10.1093/bioinformatics/bty830] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
476 González-Sarrías A, Romo-Vaquero M, García-Villalba R, Cortés-Martín A, Selma MV, Espín JC. The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial. Mol Nutr Food Res 2018;62:e1800160. [PMID: 29665619 DOI: 10.1002/mnfr.201800160] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
477 Karagöz MA, Nalbantoglu OU. Taxonomic classification of metagenomic sequences from Relative Abundance Index profiles using deep learning. Biomedical Signal Processing and Control 2021;67:102539. [DOI: 10.1016/j.bspc.2021.102539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
478 Li H, Xu H, Li Y, Jiang Y, Hu Y, Liu T, Tian X, Zhao X, Zhu Y, Wang S, Zhang C, Ge J, Wang X, Wen H, Bai C, Sun Y, Song L, Zhang Y, Hui R, Cai J, Chen J. Alterations of gut microbiota contribute to the progression of unruptured intracranial aneurysms. Nat Commun 2020;11:3218. [PMID: 32587239 DOI: 10.1038/s41467-020-16990-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
479 Kivenson V, Giovannoni SJ. An Expanded Genetic Code Enables Trimethylamine Metabolism in Human Gut Bacteria. mSystems 2020;5:e00413-20. [PMID: 33109749 DOI: 10.1128/mSystems.00413-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
480 Li H, Ni J, Qing H. Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment. Front Aging Neurosci 2021;13:671142. [PMID: 34248602 DOI: 10.3389/fnagi.2021.671142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
481 Zhao Y, Wang Z. Gut microbiome and cardiovascular disease. Curr Opin Cardiol 2020;35:207-18. [PMID: 32068612 DOI: 10.1097/HCO.0000000000000720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
482 Jayachandran M, Chung SSM, Xu B. A critical review on diet-induced microbiota changes and cardiovascular diseases. Crit Rev Food Sci Nutr 2020;60:2914-25. [PMID: 31552753 DOI: 10.1080/10408398.2019.1666792] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
483 Jie Z, Liang S, Ding Q, Li F, Sun X, Lin Y, Chen P, Cai K, Zhou H, Lu H, Wang X, Zhang T, Xiao L, Yang H, Wang J, Hou Y, Kristiansen K, Jia H, Xu X. Disease trends in a young Chinese cohort according to fecal metagenome and plasma metabolites. Medicine in Microecology 2021;9:100037. [DOI: 10.1016/j.medmic.2021.100037] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
484 Ahrens AP, Culpepper T, Saldivar B, Anton S, Stoll S, Handberg EM, Xu K, Pepine C, Triplett EW, Aggarwal M. A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study. Nutrients 2021;13:3459. [PMID: 34684459 DOI: 10.3390/nu13103459] [Reference Citation Analysis]
485 Xu J, Yang Y. Implications of gut microbiome on coronary artery disease. Cardiovasc Diagn Ther 2020;10:869-80. [PMID: 32968642 DOI: 10.21037/cdt-20-428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
486 Han W, Tang H, Ye Y. Locality-Sensitive Hashing-Based k-Mer Clustering for Identification of Differential Microbial Markers Related to Host Phenotype. J Comput Biol 2022. [PMID: 35584271 DOI: 10.1089/cmb.2021.0640] [Reference Citation Analysis]